METHOD FOR TREATING A BIOLOGICAL SAMPLE COMPRISING SPERM CELLS AND / OR SPERM NUCLEOSES AND NON-SPERM CELLS, KIT, AND USE OF A NUCLEASE

A multi-step lysis and nuclease digestion method effectively separates sperm cell DNA from non-sperm cell DNA in forensic samples, addressing inefficiencies in current techniques to enhance DNA yield and purity for reliable profiling.

BR112025024624A2Pending Publication Date: 2026-11-10QIAGEN GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
BR112025024624
Authority / Receiving Office
BR · BR
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-15
Filing Date
2024-05-14
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Current methods for separating sperm cell DNA from non-sperm cell DNA in forensic samples, particularly in cases of sexual abuse, are inefficient, time-consuming, and prone to incomplete separation, leading to mixed DNA profiles due to high numbers of non-sperm cells, resulting in low sperm DNA yield and contamination.

Method used

A method involving multiple lysis steps with specific lysis agents and nuclease digestion to selectively isolate sperm cell DNA, ensuring minimal non-sperm cell DNA contamination, including initial lysis of non-sperm cells followed by additional lysis steps to ensure complete separation.

Benefits of technology

This method enhances sperm DNA yield and purity, enabling reliable genetic profiling by minimizing non-sperm DNA contamination, particularly in sexual abuse samples, ensuring clear identification of perpetrators.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present disclosure relates to methods and kits for treatment of biological samples comprising non-sperm cells and sperm cells. The present disclosure relates more particularly to methods and kits for treatment of forensic samples comprising non-sperm cells and sperm cells. Moreover, the present disclosure relates to the use of specific enzymes for the decomposition of non-sperm DNA in a sample comprising a mixture of non-sperm DNA and sperm DNA, the sperm DNA being contained in sperm cells and / or sperm nuclei, and a corresponding method, therefore.
Need to check novelty before this filing date? Find Prior Art

Description

/ 71 METHOD FOR TREATING A BIOLOGICAL SAMPLE COMPRISING SPERM CELLS AND / OR SPERM NUCLEI AND NON-SPERM CELLS, KIT, AND USE OF A NUCLEASE FIELD

[001] This description refers to methods and kits for the treatment of biological samples comprising non-sperm cells and sperm cells. This description refers more particularly to methods and kits for the treatment of forensic samples comprising non-sperm cells and sperm cells. Furthermore, this description refers to the use of specific enzymes for the decomposition of non-sperm DNA in a sample comprising a mixture of non-sperm DNA and sperm DNA, the sperm DNA being contained in sperm cells and / or sperm nuclei, and a corresponding method for this purpose. FUNDAMENTALS

[002] The most common type of DNA profiling currently used for forensic purposes is “STR” (short tandem repeat) analysis. Short tandem repeat (STR) patterns differ between individuals and consequently DNA is used to identify individuals.

[003] In cases of sexual abuse, for example, it is essential to clearly identify all persons involved in the crime as well as the victim. Most commonly, the male perpetrator leaves sperm cells as evidence. In sexual abuse samples, the perpetrator's sperm cells are usually mixed with the victim's non-sperm cells. For STR profiling and identification, it is therefore important to separate the DNA of non-sperm cells from the DNA of sperm cells so that the STR profile of the sperm cells shows a clear male profile (of the "perpetrator") and Petition 870250103223, dated 11 / 11 / 2025, p. 104 / 182 / 71 not a mixed profile (both of the “perpetrator” and the “victim”).

[004] Sperm cells carry haploid genomes, while non-sperm cells predominantly carry diploid genomes. As a result, the amount of DNA obtained from sperm cells is noticeably less than the amount of DNA obtained from non-sperm cells. Furthermore, the amount of DNA extracted from sperm decreases with the length of time the semen remains in the victim's body. The longer the time since sexual intercourse, the less sperm DNA can be obtained and the less favorable the mixing ratio of non-sperm cells (usually mostly epithelial cells) to sperm cells becomes in living organisms.When the amount of non-sperm cell DNA, such as epithelial cell DNA, in a forensic sample is very high compared to the amount of sperm cell DNA, it is often difficult, and sometimes impossible, to remove enough of the said epithelial DNA to obtain a clean sperm DNA profile. In these cases, the result is often an undesirable mixed DNA profile.

[005] The success of genetic typing or profiling procedures largely depends on the availability of sufficient quantities of DNA of appropriate quality and purity.

[006] Extraction and separation of sperm cell DNA from DNA from non-sperm cells is largely obtained by the so-called differential digestion method developed by Gill, Jeffreys, and Werrett (“Forensic application of DNA 'fingerprints.' Nature 318, 6046 (1985): 577-579.”). In this method, non-sperm cells such as epithelial cells are first lysed with SDS and proteinase K, while sperm cells and sperm nuclei remain intact. After the removal of the lysed epithelial cells and other non-sperm cellular material, the remaining sperm fraction, which contains the nucleus, is cleaned. Petition 870250103223, dated 11 / 11 / 2025, page 105 / 182 / 71 of any residual non-sperm cell DNA through a series of centrifugation and washing steps. Finally, the sperm heads are lysed by the addition of SDS, proteinase K and dithiothreitol (DTT) which breaks the disulfide bonds that protect the sperm nucleus.

[007] Although this is the most common differential extraction method used in forensic laboratories, it is highly technique-dependent, and the quality of results can vary between analysts. Particularly in the case of sexual abuse samples, non-sperm cells are usually present in high numbers compared to sperm cells, and it is often difficult, and sometimes impossible, to remove enough non-sperm DNA as epithelial DNA to obtain a clean sperm DNA profile, and the result is often a mixed DNA profile.

[008] Furthermore, the washing steps of the sperm pellet in this method may be inefficient in removing soluble DNA from the cell pellet, leading to incomplete separation of sperm and non-sperm fractions, particularly in samples containing large numbers of victim cells relative to sperm cells. The various centrifugation and washing steps usually result in significant losses of sperm cells and sperm nuclei. This usually leads to low yields of sperm DNA insufficient for subsequent analysis.

[009] The time-consuming nature of the process often prevents this method from being a viable solution in an automated, efficiency-focused laboratory environment.

[0010] In view of the above, new methods and kits for the treatment of biological samples, such as forensic samples, including sperm cells and non-sperm cells, that overcome at least some of the problems in the technique are needed. In particular, there is a need for time- and cost-effective sample preparation protocols. Petition 870250103223, dated 11 / 11 / 2025, page 106 / 182 / 71 forensic procedure for the separation of sperm fractions from non-sperm cell fractions. SUMMARY

[0011] The present invention is generally directed to methods and kits for the treatment of biological samples comprising sperm cells and / or sperm nuclei and non-sperm cells.

[0012] It is an objective of the present description to provide an efficient method for the treatment of a biological sample comprising sperm cells and / or sperm nuclei and non-sperm cells that enables the selective isolation of sperm cells and / or sperm nuclei and sperm cell DNA that are essentially free of non-sperm cell DNA.

[0013] Another objective of the present description is to provide a method for the treatment of a forensic sample, and particularly a sexual abuse sample, comprising sperm cells and / or sperm cell nuclei and non-sperm cells, which enables the selective isolation of sperm cell DNA from said sample that is essentially free of non-sperm cell DNA.

[0014] It is a further objective of the present invention to provide a DNA profiling method that enables the reliable identification of a sperm donor and a non-sperm cell donor, particularly an epithelial cell donor, from a biological sample, particularly a forensic sample, including both sperm cells and / or sperm nuclei and non-sperm cells, such as epithelial cells.

[0015] Another objective of the present invention is to provide a kit for processing forensic samples comprising sperm cells and / or sperm nuclei and non-sperm cells.

[0016] The objectives are resolved by the resources of the independent claims. The preferred modalities are defined in the claims. Petition 870250103223, dated 11 / 11 / 2025, page 107 / 182 / 71 dependents.

[0017] In one aspect of the present description, a method for the treatment of a biological sample comprising sperm cells and / or sperm nuclei and non-sperm cells, the method comprising: (a) subjecting the biological sample comprising sperm cells and / or sperm nuclei and non-sperm cells to a first lysis by applying one or more lysis agents or a lysis solution to the biological sample and / or incubating the biological sample with one or more lysis agents or in the lysis solution, wherein the one or more lysis agents or the lysis solution are suitable for essentially lysing the non-sperm cells and for forming a first lysate comprising non-sperm DNA, sperm cells and / or sperm nuclei, wherein the one or more lysis agents or the lysis solution do not comprise any agent in an amount that causes complete lysis of sperm cells and / or sperm nuclei and preferably comprise at least one agent selected from a surfactant, a chaotropic agent, a non-sperm cell digestion enzyme, or any combination thereof; b) optionally separate and / or remove the unlysed cells and / or sperm nuclei from the first lysate comprising non-sperm DNA and / or decompose or separate or remove or separate and remove the non-sperm DNA from the first lysate comprising non-sperm DNA, sperm cells and / or sperm nuclei, preferably by subjecting the non-sperm DNA in the first lysate to digestion with nuclease; c) subjecting unlysed cells and / or sperm nuclei to at least a second lysis by applying one or more lysis agents or a lysis solution to the unlysed cells and / or sperm nuclei and / or incubating the unlysed cells and / or sperm nuclei with one or more lysis agents. Petition 870250103223, dated 11 / 11 / 2025, page 108 / 182 / 71 lysis or in the lysis solution, wherein one or more lysis agents or the lysis solution are suitable for essentially lysing non-sperm cells and for forming a second or additional lysate comprising non-sperm DNA, wherein one or more lysis agents or the lysis solution do not comprise any agent in an amount that causes complete lysis of sperm cells and / or sperm nuclei and preferably comprise at least one agent selected from a surfactant, a chaotropic agent, a non-sperm cell digestion enzyme, or any combination thereof; (d) decompose or separate or remove or separate and remove the non-sperm DNA from the second lysate or from an additional lysate comprising non-sperm DNA, preferably by subjecting the non-sperm DNA in the second lysate or in an additional lysate to digestion with nuclease; and (e) subjecting the unlysed cells to at least a third or additional lysis by applying a sperm cell and / or sperm nucleus lysis solution or one or more lysis agents to completely lyse the sperm cells and / or sperm nuclei and to form a third or additional lysate comprising sperm DNA, wherein the sperm cell and / or sperm nucleus lysis solution or the one or more lysis agents comprise at least one sperm cell and / or sperm nucleus lysis agent selected from a reducing agent, a sperm cell and / or sperm nucleus lysis enzyme, a chaotropic agent at a concentration suitable for lysing a sperm cell and / or sperm nuclei and / or an alkaline agent at a concentration suitable for lysing sperm cells and / or sperm nuclei or a combination thereof.

[0018] In one embodiment, the method described further comprises purifying, isolating, detecting, analyzing and / or quantifying non-sperm cells and / or sperm cell DNA. In a preferred embodiment, Petition 870250103223, dated 11 / 11 / 2025, page 109 / 182 / 71 analysis comprises genotyping the DNA, preferably a short tandem repeat (STR) analysis, restriction fragment length polymorphism (RFLP) of genomic DNA, randomized amplified polymorphic detection (RAPD) of genomic DNA, amplified fragment length polymorphism (AFLP) detection, single nucleotide polymorphism (SNP) detection, polymerase chain reaction (PCR), DNA sequencing, allele-specific oligonucleotide (ASO) probes, and hybridization to DNA microarrays or microspheres; or any combination thereof.

[0019] In another aspect, the present description provides kits for the treatment of biological samples, such as forensic samples, comprising non-sperm cells and sperm cells, the kit comprising one or more of: a) a first non-sperm cell lysis solution or one or more non-sperm cell lysis agents capable of lysing non-sperm cells and essentially not suitable for completely lysing sperm cells and / or sperm nuclei; (b) a second non-sperm cell lysis solution and / or an additional or one or more non-sperm cell lysis agents capable of lysing non-sperm cells but not suitable for completely lysing sperm cells and / or sperm nuclei, wherein the second non-sperm cell lysis solution and / or an additional or one or more non-sperm cell lysis agents is / are identical to the first non-sperm cell lysis solution or to the one or more non-sperm cell lysis agents used in (a), or wherein the second non-sperm cell lysis solution and / or an additional or one or more non-sperm cell lysis agents is / are different from the first non-sperm cell lysis solution or the one or more non-sperm cell lysis agents used in (a); Petition 870250103223, dated 11 / 11 / 2025, page 110 / 182 / 71 c) optionally, one or more washing compositions; d) optionally one or more DNA digestion enzymes; (e) a solution for lysing sperm cells and / or sperm nuclei or one or more sperm cell and / or sperm nucleus lysis agents capable of lysing sperm cells and / or sperm nuclei, preferably the sperm cell and / or sperm nucleus lysis solution or one or more lysis agents comprising at least one reducing agent selected from the group consisting of dithiothreitol (DTT), dithioerythrityl, β-mercaptoethanol (BME), glutathione (GSH), Tris(2-carboxyethyl)phosphine (TCEP) and combinations thereof; a sperm lysing enzyme selected from the group consisting of proteinase K, protease, zymolase, lyticase, chromopeptidase, trypsin, lysostaphin, lysozyme and / or combinations thereof; a chaotropic agent at a concentration suitable for lysing sperm cells and / or sperm nuclei and / or an alkaline agent at a concentration suitable for lysing a sperm cell and / or sperm nuclei; or any combination thereof.BRIEF DESCRIPTION OF THE FIGURES.

[0020] Fig. 1A shows the amount of DNA isolated from a female cell sample after the sample was subjected to a first lysis (“supernatant”), after digestion with DNase and after the second lysis (“2-lysis”) of the sample. The DNA yield is plotted on a logarithmic scale (A).

[0021] Fig. 1B shows the amount of DNA isolated from a female cell sample after the sample was subjected to a first lysis (“supernatant”), after digestion with DNase and after the second lysis (“2-lysis”) of the sample. The DNA yield is plotted on a linear scale with a broken Y-axis (B).

[0022] Fig. 2 shows STR DNA profiles of an isolated epithelial cell fraction subjected to initial lysis (“supernatant”), digestion Petition 870250103223, dated 11 / 11 / 2025, page 111 / 182 / 71 with DNase and second lysis (“2alise”).

[0023] Fig. 3a shows the amount of DNA recovered from the non-sperm fraction of a sample containing mixed epithelial and sperm cells.

[0024] Fig. 3b shows the amount of autosomal DNA and male DNA recovered from the sperm cell fraction of a sample containing mixed epithelial and sperm cells after 1 lysis step and 1ae 2 analyses of the non-sperm fraction.

[0025] Fig. 4 shows STR profiles of DNA recovered from the non-sperm fraction and the sperm fraction of a sample containing epithelial and sperm cells that was subjected to 1ae 2alises of the non-sperm fraction.

[0026] Fig. 5A shows the amount of remaining DNA isolated from female cell samples after the sample was subjected to a first lysis followed by digestion with DNase (“after DNase digestion”) and after a second lysis (“2lysis”), in which different lysis buffers were used. The DNA yield is plotted on a logarithmic scale.

[0027] Fig. 5B shows the amount of remaining DNA isolated from female cell samples after the sample was subjected to a first lysis followed by digestion with DNase (“after digestion with DNase”) and after a second lysis (“2lysis”), in which different lysis buffers were used. The DNA yield is plotted on a linear scale with a broken Y-axis (B).

[0028] Fig. 6a shows the concentration of autosomal DNA and male DNA recovered from a sperm cell fraction of a sample containing sperm cells after lysis of non-sperm cells and washing of the resulting sperm cell pellet, enriched with female gDNA, without digestion and after digestion with RecBCD or after Petition 870250103223, dated 11 / 11 / 2025, page 112 / 182 / 71 digestion with DNase I.

[0029] Fig. 6b shows the DNA degradation ratio of autosomal DNA and male DNA recovered from a sperm cell fraction of a sperm cell-containing sample after lysis of non-sperm cells and washing of the resulting sperm cell pellet, enriched with female gDNA, without digestion and after digestion with RecBCD or after digestion with DNase I.

[0030] Fig. 7 shows STR profiles of DNA recovered from a sperm cell fraction of a sample containing sperm cells after lysis of non-sperm cells and washing of the resulting sperm cell pellet, enriched with female gDNA, without digestion and after digestion with RecBCD or after digestion with DNase I. DETAILED DESCRIPTION OF THE MODALITIES

[0031] Reference will now be made in detail to the various preferred modalities of the description, one or more examples of which are illustrated in the figures. Additionally, features illustrated or described as part of a modality may be used in or in conjunction with other modalities to produce yet another modality. It is intended that the description include such modifications and variations.

[0032] The term “biological sample” or “sample” as used in the present invention broadly refers to a sample containing biological materials, preferably mammalian biological material such as human and animal, such as blood, bloodstains, saliva, saliva stains, skin fragments, feces, fecal stains, urine, vaginal specimens, perianal specimens, anorectal specimens, semen, sperm cells and non-sperm cells such as epithelial cells. The term covers samples that are directly obtained from a human donor, but also refers to samples in which biological conditions are artificially imitated, for example, for in vitro testing, in particular for Petition 870250103223, dated 11 / 11 / 2025, page 113 / 182 / 71 research purposes.

[0033] The term “biological sample” or “sample”, as used herein, preferably additionally refers to a biological sample that is fixed, adsorbed, absorbed or otherwise in contact with swabs, such as “sample swabs” or “forensic sample swabs”, preferably swabs comprised of various materials such as natural fiber (like cotton) or synthetic matrices, or any other material on which the sample can be collected or is examined.

[0034] The term “forensic sample,” as used herein, refers to a biological sample collected for forensic analysis and examination. Forensic sample collection is usually carried out, for example, by collecting a sample on a swab or other collection methods using collection cards, such as FTA® collection cards, collecting sections of the area of ​​interest, such as a biological fluid on clothing or on a section of clothing or any other material on which the sample of interest is located or to which it is connected. Forensic samples may also be checked, for example, on the ground, on any other type of fabric, such as sheets, blankets, covers, towels, handkerchiefs or similar, or on other non-fabric clothing, such as shoes, leather clothing, synthetic material, or on any other type of solid support that has been in contact with a participant at the crime scene.

[0035] The term “non-sperm cells,” as used herein, refers to all cell types other than sperm cells, including but not limited to erythrocytes, platelets, neutrophils, lymphocytes, monocytes, eosinophils, basophils, adipocytes, chondrocytes, pancreatic islet cells, thyroid cells, parathyroid cells, parotid cells, tumor cells, neurons, glial cells, astrocytes, red blood cells, white blood cells, macrophages, epithelial cells, somatic cells, pituitary cells, adrenal cells, hair cells, bladder cells, renal cells, Petition 870250103223, dated 11 / 11 / 2025, page. 114 / 182 / 71 retinal cells, rods, cone cells, cardiac cells, pacemaker cells, spleen cells, antigen-presenting cells, memory cells, T cells, B cells, plasma cells, muscle cells, ovarian cells, uterine cells, prostate cells, vaginal epithelial cells, testicular cells, germ cells, ova, Leydig cells, peritubular cells, Sertoli cells, lutein cells, cervical cells, endometrial cells, mammalian cells, follicular cells, mucous cells, ciliated cells, non-keratinized epithelial cells, keratinized epithelial cells, lung cells, goblet cells, columnar epithelial cells, squamous epithelial cells, osteocytes, osteoblasts, osteoclasts, and epithelial cells.

[0036] The term “sperm cell”, as used herein, refers to the reproductive cell of a male animal, preferably a male mammal such as a human. The term “sperm cell nuclei” or “sperm nuclei”, as used herein, refers to the cell nucleus located in the head of the sperm cell of two or more sperm cells.

[0037] As used herein, the term “non-sperm cell DNA” refers to any DNA that is present in “non-sperm cells”.

[0038] The term “lysate” as used here refers to a mixture containing lysed cell fragments and DNA.

[0039] The term “complete lysis” refers to lysis in which 100%, 99% or more, 98% or more, 97% or more, 96% or more, 95% or more, 94% or more, 93% or more, 92% or more, 91% or more, 90% or more, 88% or more of the cells, preferably the sperm cells and / or nuclei to be lysed, have lost their cellular integrity and / or the nucleic acids, in particular the sperm nucleic acids, are exposed. Lysis of sperm cells and sperm nuclei may be independent of each other. That is, the sperm cells may have been predominantly lysed Petition 870250103223, dated 11 / 11 / 2025, p. 115 / 182 / 71 while the sperm nuclei are still intact such that the sperm nucleic acids, at least to some degree, are not yet exposed.

[0040] A method and kits are provided here for the treatment of a biological sample comprising sperm cells and / or sperm nuclei and non-sperm cells that enable the selective isolation of sperm cell DNA that is essentially free of non-sperm cell DNA.

[0041] In particular, the methods of the present description are provided for the treatment of a forensic sample, preferably a sexual abuse sample, comprising sperm cells and / or sperm nuclei from the perpetrator which are in many cases mixed with non-sperm cells from the victim, the quantity of non-sperm cells from the victim usually even exceeding tremendously the quantity of sperm cells and / or sperm nuclei. The methods of the present description enable the isolation of sperm cell DNA that is suitable for further analysis, such as genotyping, that is, to enable the identification of the perpetrators.

[0042] Minimizing the loss of target DNA during extraction, as well as ensuring complete lysis of cells containing the target DNA, are two factors that must be considered when choosing an extraction method. This is particularly relevant when DNA is extracted from forensic samples, such as sexual abuse samples, where sperm cell DNA from the perpetrator(s) is usually present along with non-sperm cell DNA from the victim. The purity and quality of the DNA will be paramount for detection, analysis, and profiling in order to clearly identify the individual, for example, based on their unique STR profile.

[0043] In the preparation of forensic samples, the first step usually involves the lysis of non-sperm cells, such as epithelial cells, followed by the subsequent lysis of intact sperm cells. Petition 870250103223, dated 11 / 11 / 2025, page 116 / 182 / 71 remaining.

[0044] In a novel approach, as specified in the method of the present description, the non-sperm cells present in a biological sample comprising sperm cells and / or sperm nuclei and non-sperm cells are lysed in a first lysis step followed by at least one second lysis step under conditions where intact or essentially intact non-sperm cells are lysed, however the sperm cells and sperm nuclei have not been lysed or not completely.

[0045] Surprisingly, it has been found that the first lysis step does not result in complete lysis of non-sperm cells. Instead, enough non-sperm cells remain that, if not removed in a second or additional lysis procedure, are found to contaminate sperm cells and sperm nuclei. Failure to sufficiently remove said contaminating non-sperm cells will also result in contamination of sperm DNA with non-sperm DNA once the sperm cells and sperm nuclei are lysed.

[0046] Consequently, a second or additional lysis will ensure that any intact or essentially intact non-sperm cells that were not lysed during the first treatment step will be lysed during a second or additional step.

[0047] Once essentially all non-sperm cells present in the biological sample have been lysed and the non-sperm DNA has been separated, removed and / or broken down and / or digested, the sperm cells and / or nuclei are lysed to obtain the sperm DNA.

[0048] Repeated treatment of the sample according to the method described, and in particular treating the non-sperm fraction present in the sample, with a lysis solution or one or more suitable lysis agents to lyse the non-sperm cells, optionally decomposing and / or Petition 870250103223, dated 11 / 11 / 2025, page 117 / 182 / 71, removing non-sperm DNA after each lysis step of the non-sperm cell and before sperm cells or sperm nuclei are lysed, will maximize the yield and purity of sperm DNA isolated from said samples and in particular reduce contamination of sperm DNA with non-sperm DNA. This is particularly important in the analysis of sexual abuse samples, where separation of the perpetrator's DNA from the victim's DNA is crucial for subsequent genetic typing or profiling procedures.

[0049] The method described herein allows for the efficient separation of sperm cells and sperm nuclei from forensic swabs, minimal sperm cell loss during treatment, and highly efficient sperm lysis after purification of sperm cells and sperm nuclei.

[0050] The method described herein additionally allows for efficient isolation of sperm DNA from other types of DNA in a sample. Cross-contamination of sperm DNA with non-sperm DNA is substantially eliminated. This will maximize the yield and purity of the sperm DNA isolated from said samples and thus allows for reliable detection, analysis and individual identification of DNA using, for example, STR profiling.

[0051] In one embodiment, the present description provides a method for the treatment of a biological sample comprising sperm cells and / or sperm nuclei and non-sperm cells, the method comprising: a) subjecting the biological sample comprising sperm cells and / or sperm nuclei and non-sperm cells to initial lysis by applying one or more lysis agents or a lysis solution to the biological sample and / or incubating the biological sample with one or more lysis agents or in the lysis solution, wherein the one or more lysis agents or Petition 870250103223, dated 11 / 11 / 2025, page 118 / 182 / 71 the lysis solution is suitable for essentially lysing non-sperm cells and for forming a first lysate comprising non-sperm DNA, sperm cells and / or sperm nuclei, wherein one or more lysis agents or the lysis solution does not comprise any agent in an amount that causes complete lysis of the sperm cells and / or sperm nuclei and preferably comprises at least one agent selected from a surfactant, a chaotropic agent, a non-sperm cell digestion enzyme, or any combination thereof; b) optionally separate and / or remove the unlysed cells and / or sperm nuclei from the first lysate comprising non-sperm DNA and / or decompose or separate or remove or separate and remove the non-sperm DNA from the first lysate comprising non-sperm DNA, sperm cells and / or sperm nuclei, preferably by subjecting the non-sperm DNA in the first lysate to digestion with nuclease; (c) subjecting unlysed cells and / or sperm nuclei to at least a second lysis by applying one or more lysis agents or a lysis solution to the unlysed cells and / or sperm nuclei and / or incubating the unlysed cells and / or sperm nuclei with one or more lysis agents or in the lysis solution, wherein the one or more lysis agents or the lysis solution are suitable for essentially lysing non-sperm cells and for forming a second or additional lysate comprising non-sperm DNA, wherein the one or more lysis agents or the lysis solution do not comprise any agent in an amount that causes complete lysis of sperm cells and / or sperm nuclei and preferably comprise at least one agent selected from a surfactant, a chaotropic agent, a non-sperm cell digestion enzyme, or any combination thereof; d) decompose or separate or remove or separate and remove the Petition 870250103223, dated 11 / 11 / 2025, page 119 / 182 / 71 Non-sperm DNA from the second lysate or from an additional lysate comprising non-sperm DNA, preferably by subjecting the non-sperm DNA in the second lysate or in an additional lysate to digestion with nuclease; and (e) subjecting the unlysed cells to at least a third or additional lysis, applying a sperm cell and / or sperm nucleus lysis solution or one or more lysis agents to completely lyse the sperm cells and / or sperm nuclei and to form a third or additional lysate comprising sperm DNA, wherein the lysis solution or the one or more sperm cell and / or sperm nucleus lysis agents comprise(s) at least one sperm cell and / or sperm nucleus lysis agent selected from a reducing agent, a sperm cell and / or sperm nucleus lysis enzyme, a chaotropic agent at a concentration suitable for lysing a sperm cell and / or sperm nuclei, or a combination thereof.

[0052] In some embodiments, the biological sample is a forensic sample, such as a forensic swab sample, preferably a sexual abuse sample.

[0053] In one embodiment, the forensic sample is a sample collected on a sample holder, such as a swab, a cut, or a collection card, such as an FTA® collection card. Preferably, the sample is collected on a swab.

[0054] In one embodiment, the forensic sample is a sexual abuse sample comprising a mixture of cells from the victim and a perpetrator, in some cases even more than one perpetrator. In a further embodiment, the victim's cells are non-sperm cells, such as epithelial cells, and the perpetrator's cells comprise sperm cells and / or sperm nuclei, although they may also comprise non-sperm cells such as epithelial cells, for example, from the skin or hair. Petition 870250103223, dated 11 / 11 / 2025, page 120 / 182 / 71

[0055] In one embodiment of the description, the biological sample is treated with a lysis solution or one or more lysis agents comprising an adequate amount of an agent under conditions that essentially promote lysis of non-sperm cells but do not promote complete lysis of sperm cells and sperm nuclei. In a novel approach, the unlysed cells are subjected to repeated lysis under conditions that essentially promote lysis of non-sperm cells but do not promote complete lysis of sperm cells and / or sperm nuclei.

[0056] In one embodiment of the description, the biological sample comprising sperm cells and / or sperm nuclei and non-sperm cells is subjected to a first lysis by applying one or more lysis agents or a lysis solution to the biological sample and / or incubating the biological sample with one or more lysis agents or in the lysis solution, wherein the one or more lysis agents or the lysis solution are suitable for essentially lysing the non-sperm cells and for forming a first lysate comprising non-sperm DNA. The one or more lysis agents or the lysis solution do not comprise any agent in an amount that causes complete lysis of sperm cells and / or sperm nuclei and preferably comprise at least one agent selected from a surfactant, a chaotropic agent, a non-sperm cell digestion enzyme, or any combination thereof.However, lysis can induce partial lysis of sperm cells and / or sperm nuclei or their membrane such that no significant amount of sperm DNA is released in this way.

[0057] In one embodiment of the description, in the method step a) one or more lysis agents or the lysis solution is applied to or contacted with the biological sample to form a first lysate comprising non-sperm DNA. Petition 870250103223, dated 11 / 11 / 2025, page 121 / 182 / 71

[0058] In one embodiment, the lysis agents are not contacted with the biological sample in the form of a pre-prepared lysis solution, but the biological sample is contacted directly with one or more lysis agents. This is particularly applicable if the biological sample is a liquid sample or dissolved in a liquid before being brought into contact with one or more lysis agents. Preferably, the lysis agents are readily dissolvable in the liquid sample material or in the dissolved sample. Alternatively, the lysis agent may be pre-lysed in a solvent and contacted with the biological sample in the form of a lysis solution. The combination of the biological sample with one or more lysis agents and / or the lysis solution results in the lysis mixture or lysate once lysis has proceeded.

[0059] In a further embodiment of the description, in method step a) one or more lysis agents or lysis solution are / are applied to or contacted with the biological sample, and the biological sample is then incubated with one or more lysis agents or in the lysis solution to form a first lysate comprising non-sperm DNA.

[0060] In a further embodiment of the description, following the first lysis of the sample with the lysis solution or one or more lysis agents, the unlysed cells are separated from the first lysate comprising non-sperm DNA and / or the first lysate comprising released non-sperm DNA is removed from the sperm cell fraction or sperm nuclei and / or the non-sperm DNA comprised in the first lysate is decomposed or separated or removed or separated and removed from the first lysate comprising non-sperm DNA, sperm cells and / or sperm nuclei, preferably by subjecting the non-sperm DNA in the first lysate to digestion with nuclease. In certain embodiments of the description, the separation of the unlysed cells from the first lysate occurs by centrifugation. The lysed sample from step a) is subjected to Petition 870250103223, dated 11 / 11 / 2025, page 122 / 182 / 71 centrifugation in order to separate the lysed sample into a lysate comprising non-sperm DNA and non-lysed cells, preferably forming a pellet containing non-lysed cells and a lysed supernatant comprising non-sperm DNA.

[0061] In one embodiment, the resulting supernatant comprising lysed non-sperm cell DNA is subsequently removed from the non-lysed cells or cell pellet by any suitable means, including but not limited to pipetting. In other embodiments, the non-lysed cells are separated by filtration.

[0062] In another embodiment, the unlysed cells are separated by any suitable method or means, such as microsphere separation, preferably magnetic microsphere separation, or by attaching specific unlysed cells to a solid matrix, such as a membrane or microspheres, preferably magnetic microspheres, more preferably with the aid of antibodies (e.g., selective cell capture).

[0063] The removal or separation of DNA, in particular non-sperm DNA, can occur with any suitable means including precipitation, centrifugation, filtration, microbead separation, preferably magnetic microbead separation, binding to a non-particulate solid matrix, for example, a membrane, or incubation with a nuclease.

[0064] In a preferred embodiment, the non-sperm DNA included in the first lysate is broken down, preferably by subjecting the non-sperm DNA to digestion with nuclease.

[0065] Following the first lysis, the unlysed cells are subjected to a second or additional lysis step, applying one or more lysis agents or a second or additional lysis solution to the unlysed cells and / or incubating the unlysed cells with one or more lysis agents or in Petition 870250103223, dated 11 / 11 / 2025, page 123 / 182 / 71 second or additional lysis solution. One or more lysis agents or the second or additional lysis solution is / is suitable for essentially lysing non-sperm cells and for forming a second or additional lysate comprising non-sperm DNA. The second or additional lysis solution does not comprise any agent in an amount that causes complete lysis of sperm cells and / or sperm nuclei and preferably comprises at least one agent selected from a surfactant, a chaotropic agent, a non-sperm cell digestion enzyme, or any combination thereof.

[0066] In one embodiment of the description, in method step c) the second or additional lysis solution is applied to the unlysed cells to form a second or additional lysate comprising non-sperm DNA.

[0067] In one embodiment, the lysis agents are not contacted with the unlysed cells in the form of a pre-prepared lysis solution, but one or more lysis agents are contacted directly with the unlysed cells. This is particularly applicable if the unlysed cells have been resuspended in a liquid before or during contact with one or more lysis agents.

[0068] In one embodiment, the unlysed cells remain after the first lysis step has not been separated from the lysate (liquid) comprising the non-sperm DNA, but the second lysis solution or the lysis agent for the second lysis is contacted with the lysate from the first lysis step (a). Said lysate includes the non-sperm DNA released from the non-sperm cells, any non-sperm cells that were not lysed in the first lysis step, and the unlysed sperm cells and / or sperm nuclei.

[0069] In one embodiment, unlysed cells remain after the second or any additional lysis step has not been separated from Petition 870250103223, dated 11 / 11 / 2025, page 124 / 182 / 71 lysate (liquid) comprising non-sperm DNA, but the lysis solution, the second or additional lysis solution, or the lysis agent for the second or additional lysis are contacted with the lysate from the previous lysis step(s). Said lysate includes non-sperm DNA released from non-sperm cells, any non-sperm cells that have been lysed in the previous lysis step(s), and unlysed sperm cells and / or sperm nuclei.

[0070] In one embodiment of the description, in method step c) the lysis solution, the second or additional lysis solution, or one or more lysis agents is / are applied to the separated non-lysed cells, the one or more lysis agents for the second or additional lysis are contacted with the non-lysed cells, which are preferably resuspended, or the one or more lysis agents for the second or additional lysis in a pre-dissolved form or directly are contacted with the complete lysate including the lysate from the first or any previous lysis step(s), and the non-lysed cells are incubated with the one or more lysis agents or in the second or additional lysis solution to essentially lyse non-sperm cells and to form a second or additional lysate comprising non-sperm DNA.

[0071] In one embodiment, the non-sperm DNA present in the first lysate is decomposed or separated or removed or separated and removed from the first lysate comprising said non-sperm DNA, preferably by subjecting the non-sperm DNA in the first lysate to digestion with nuclease, more preferably to digestion with Exonuclease V (RecBCD).

[0072] In one embodiment, the non-sperm DNA present in the first lysate is decomposed or separated or removed or separated and removed from the first lysate comprising said non-sperm DNA, preferably after step a) and before step c). Preferably, the non-sperm DNA in the first lysate as such is subjected to a Petition 870250103223, dated 11 / 11 / 2025, page 125 / 182 / 71 digestion with nuclease, more preferably with Exonuclease V (RecBCD). Optionally, after digestion with nuclease, the non-lysed cells, including non-lysed sperm cells and / or sperm nuclei, are additionally separated and removed from the digested lysate for further treatment. Alternatively, in one embodiment, after digestion with nuclease, the resulting complete mixture, including digested non-sperm DNA, is used for treatment according to step c), i.e., without separation or removal of the non-lysed cells, including non-lysed sperm cells and / or sperm nuclei, from the digested lysate and the digested non-sperm DNA.

[0073] In a further embodiment, the non-sperm DNA present in the first lysate is separated and removed from the first lysate comprising said non-sperm DNA according to step b), and before step c), the non-sperm DNA still contaminating the non-lysed cells, including the non-lysed sperm cells and / or sperm nuclei, is preferably decomposed by subjecting the non-sperm DNA in the separated and removed non-lysed cells to nuclease digestion, more preferably to digestion with Exonuclease V (RecBCD). Optionally, after nuclease digestion, the non-lysed cells, including the non-lysed sperm cells and / or sperm nuclei, are further separated and removed from the digested non-lysed cell mixture for further treatment, i.e., the digested non-sperm DNA is removed from the remaining non-lysed cell mixture.

[0074] Alternatively, in one embodiment, after digestion with nuclease the resulting complete mixture, i.e., including the digested non-sperm DNA as well as the mixture of unlysed cells, is used for treatment according to step c), i.e., without separating or removing the unlysed cells, including the unlysed sperm cells and / or sperm nuclei, from the digested non-sperm DNA in the mixture of Petition 870250103223, dated 11 / 11 / 2025, p. 126 / 182 / 71 unlysed cells.

[0075] In a further embodiment, the non-sperm DNA present in the first lysate is decomposed or separated or removed or separated and removed from the first lysate comprising said non-sperm DNA, preferably after step a) and / or b) and before step c), preferably by subjecting the non-sperm DNA in the first lysate to digestion with nuclease, more preferably with an Exonuclease V (RecBCD). Thus, the step of decomposing or decomposing and removing, optionally decomposing, separating and removing, the non-sperm DNA from the first lysate can be repeated once, twice or several times to ensure the decomposition and removal of as much of the non-sperm DNA as possible.

[0076] In one embodiment of the description, this additional lysis step c) is repeated once, twice, or several times to ensure complete lysis of non-sperm DNA.

[0077] The terms “lysis solution”, “first lysis solution” and / or “second lysis solution” as used herein, refer to a lysis solution comprising at least one agent capable of lysing cells, preferably non-sperm cells, and do not comprise any agent in an amount that causes complete lysis of sperm cells and / or sperm nuclei.

[0078] The term “one or more lysis agents” as used herein refers to a lysis agent capable of lysing cells, preferably non-sperm cells, and does not include any agent in an amount that causes complete lysis of sperm cells and / or sperm nuclei.

[0079] In one embodiment of the present description, the lysis solution, the first lysis solution, the second lysis solution, or one or more lysis agents comprise at least one chaotropic compound. In a preferred embodiment, the chaotropic compound is selected from a group Petition 870250103223, dated 11 / 11 / 2025, p. 127 / 182 / 71 consisting of sodium salts, a thiocyanate salt or guanidinium salts or urea, preferably a sodium iodide, sodium perchlorate, guanidinium hydrochloride, guanidinium thiocyanate, guanidinium isothiocyanate and / or a mixture of two or more salts thereof. The chaotropic compound is preferably a guanidinium salt, such as guanidinium hydrochloride, guanidinium thiocyanate and / or guanidinium isothiocyanate.

[0080] Suitable concentrations and amounts of chaotropic compounds may vary depending on the nature of the samples or lysis parameters, with concentrations of the chaotropic compound in the range of > 0.0001 mM to < 10 M generally being favorable, based on the total volume of the lysis solution or lysate, respectively. Preferably, the concentrations of the chaotropic compound are in the range of > 0.005 mM to < 8 M, preferably in the range of > 0.1 M to < 8 M, more preferably in the range of > 0.4 M to < 7 M, particularly preferably in the range of > 0.4 M to < 6 M, such as 0.5 M, 1 M, 1.5 M, 2 M, 2.5 M, 3 M, 3.5 M, 4 M, 4.5 M, 5 M, 5.5 M and 6 M, based on the total volume of the lysis solution or lysate, respectively.

[0081] In another embodiment of the present description, the lysis solution, the first lysis solution, the second lysis solution, or one or more lysis agents comprise at least one agent selected from surfactants. Surfactants, often also referred to as detergents, comprise ionic surfactants such as anionic and cationic surfactants, zwitterionic surfactants, and nonionic surfactants.

[0082] In another embodiment of the present description, the lysis solution, the first lysis solution, the second lysis solution, or one or more lysis agents comprise at least one agent selected from surfactants, wherein the surfactant(s) have one or more of the following features: i) the surfactant is selected from an anionic surfactant; Petition 870250103223, dated 11 / 11 / 2025, page 128 / 182 / 71 ii) the surfactant is selected from a non-ionic surfactant; iii) the surfactant is selected from an anionic and / or a non-ionic surfactant; iv) the surfactant is selected from among a cationic surfactant; (v) the surfactant is selected from a zwitterionic surfactant; vi) the surfactant is selected from two or more of the surfactants indicated in i. av); vii) the anionic surfactant is selected from the group consisting of sodium dodecyl sulfate (SDS), sarcosyl deoxycholate, sodium lauryl ether sulfate (SLS), sodium octyl sulfate (SOS), sodium methyl cocoyl taurate and disodium coco sulfosuccinates, or a combination thereof; viii) The nonionic surfactant is selected from the group consisting of Triton X-100, Triton X-114, N-octylglucoside, Tween 20 (polysorbate 20, polyoxyethylene (20) sorbitan monolaurate), Tween 40, Tween 80, Span 80, Span 85, Ecosurf EH-6, Brij-35 (polyalkylene glycol ether), NP-40 (nonylphenoxypolyethoxyethanol), Nonidet P-40 (octylphenoxypolyethoxyethanol), Ecosurf EH-9, Ecosurf SA-9, Tergitol 15-S-7, Tergitol 15-S-9, Tergitol 15-S-15, Tergitol 15-S-30, Tergitol 15-S-40, Tergitol 15-S-5, Brij35, Brij C10 (=Brij 56), Brij58, BrijS20 (=Brij78), Brij98, Poloxamer 188 (=Synperonic F68), Genapol X-080, Genapol X-100, Genapol X-150, Genapol C-100, Genapol C-200, Genapol X-050, Genapol X060, Pluronic F-127, MEGA-8, MEGA-9, MEGA-12, MEGA-10, APO-10, APO-12, Big CHAP, Big CHAP Deoxy, Pluronic P-123, Pluronic L64 and Pluronic 17R4, or a combination thereof.

[0083] In one embodiment of the description, the lysis solution, the first lysis solution, the second lysis solution, or one or more lysis agents comprise an agent selected from anionic surfactants comprising, for example, sodium dodecyl sulfate (SDS), sarcosyl, Petition 870250103223, dated 11 / 11 / 2025, page 129 / 182 / 71 deoxycholate, sodium lauryl ether sulfate (SLS), sodium octyl sulfate (SOS), sodium methyl cocoyl taurate and disodium coco sulfosuccinates, or a combination thereof.

[0084] In one embodiment of the description, the lysis solution, the first lysis solution, the second lysis solution, or one or more lysis agents comprise an agent selected from cationic surfactants comprising, for example, cetyltrimethylammonium bromide (CTAB), cetyltrimethylammonium chloride (CTAC), cetylpyridinium chloride (CPC), benzalkonium chloride (BAC), benzethonium chloride (BZT), 5-bromo-5-nitro-1,3-dioxane, dimethyldioctadecylammonium chloride, cetrimonium bromide, dioctadecyldimethylammonium bromide (DODAB), dodecyltrimethylammonium bromide (DOTAB), or a combination thereof.

[0085] In one embodiment of the description, the lysis solution, the first lysis solution, the second lysis solution, or one or more lysis agents comprise an agent selected from among nonionic surfactants comprising, for example, Triton X-100, Triton X-114, N-octylglucoside, Tween 20 (polysorbate 20, polyoxyethylene (20) sorbitan monolaurate), Tween 40, Tween 80, Span 80, Span 85, Ecosurf EH-6, Brij-35 (polyalkylene glycol ether), NP-40 (nonylphenoxypolyethoxyethanol), Nonidet P-40 (octylphenoxypolyethoxyethanol), Ecosurf EH-9, Ecosurf SA-9, Tergitol 15-S-7, Tergitol 15-S-9, Tergitol 15-S-15, Tergitol 15-S-30, Tergitol 15-S-40, Tergitol 15-S-5, Brij35, Brij C10 (=Brij 56), Brij58 (polyalkylene glycol ether), BrijS20 (=Brij78), Brij98, Poloxamer 188 (=Synperonic F68), Genapol X-080, Genapol X-100, Genapol X-150, Genapol C-100, Genapol C-200, Genapol X-050, GenapolPluronic P-123, Pluronic L64 and Pluronic 17R4, or a combination thereof.

[0086] In one form of the description, the lysis solution, the first Petition 870250103223, dated 11 / 11 / 2025, page 130 / 182 / 71 lysis solution, the second lysis solution or one or more lysis agents comprise an agent selected from zwitterionic surfactants comprising for example Zwittergent 3-08, Zwittergent 3-12, Zwittergent 3-16, Zwittergent 3-10, phospholipids phosphatidylserine, phosphatidylethanolamine, phosphatidylcholine, sphingomyelins, 3-[(3-Cholamidopropyl)-dimethylammonium]propanesulfonate (CHAPS), and 3-([3-Cholamidopropyl]dimethylammonium)-2-hydroxy-1-propanesulfonate (CHAPSO), or a combination thereof.

[0087] The appropriate concentrations and amounts of surfactant may vary depending on the nature of the samples or lysis parameters, with surfactant concentrations in the range of 0.1 mM to 5 M, or in the range of 0.005% to 4%, generally being favorable, based on the total volume of the lysis solution or the lysis mixture with the biological sample comprising one or more lysis agents, respectively. The concentrations and amounts of the surfactant are in the range of 0.05% to 4%, 0.05 to 3%, 0.05 to 2%, 0.05 to 1.0%, 0.05 to 0.5%, 0.05 to 0.1%, preferably in the range of 0.1 to 2.5%, 0.1 to 2.0%, 0.1 to 1.5%, 0.1 to 1.0%, 0.1 to 0.5%, more preferably in the range of 0.30 to 2%, 0.3 to 1.75%, 0.3 to 1.5%, 0.3 to 1.0%, or any suitable concentration within this range, based on the total volume of the lysis solution or the lysis mixture with the biological sample comprising one or more lysis agents, respectively.

[0088] In one embodiment of the present description, the lysis solution, the first lysis solution, the second lysis solution, or one or more lysis agents comprise at least one agent selected from enzymes that digest non-sperm cells, in particular, for example, proteinase K (QIAGEN), protease, zymolase, lyticase, chromopeptidase, lysostaphin, lysozyme, or any combination thereof.

[0089] The lysis agent may also be successively added to or contacted with the biological mixture by the subsequent addition of one or more of the lysis agent or by the addition of one or more additional lysis solutions. Petition 870250103223, dated 11 / 11 / 2025, p. 131 / 182 / 71 to result in the final lysis mixture.

[0090] According to a preferred additional embodiment, the lysis solution, which may be the first lysis solution comprising one or more lysis agents, the second lysis solution comprising one or more lysis agents, or any additional lysis solution comprising one or more lysis agents, the one or more lysis agents, or the mixture of the lysis solution or the lysis agent with the biological sample, has a pH in the range of > 4 to < 12, in particular in the range of > 5 to < 11, preferably in the range of > 6 to < 10, especially preferably in the range of > 6 to < 9. Each lysis solution, lysis agent, mixture of biological sample with lysis solution, or lysis agent used may have the same pH value as specified, or the individual lysis solutions may have different pH values ​​from each other while still preferably being within the specified range.

[0091] In one embodiment of the description, the biological sample and / or unlysed cells are incubated during lysis for a period of 10 minutes to 2 hours and more, preferably 10 minutes, 20 minutes, 30 minutes, 40 minutes, 50 minutes, 60 minutes, 75 minutes, 90 minutes or 120 minutes, or any suitable incubation time within this range.

[0092] The lysis agent may also be successively added to or contacted with the biological mixture by subsequently adding one or more of the lysis agent or by adding one or more additional lysis solutions to result in the final lysis mixture.

[0093] In one embodiment of the description, the one or more lysis agents or the lysis solution applied in method step c) comprise(s) the same agents in the same concentration and / or quantity as the one or more lysis agents or the lysis solution applied in method step a).

[0094] In another embodiment, one or more lysis agents or the lysis solution applied in method step a) and one or more lysis agents or the lysis solution applied in method step c) are different in at least Petition 870250103223, dated 11 / 11 / 2025, page 132 / 182 / 71 less one agent and / or at least one concentration or quantity of agent.

[0095] The lysis solution can be pre-prepared by dissolving the lysis agent in a solvent, or the lysis agent can be added directly to the sample in step a) or to the unlysed cells in step c) or their respective resuspensions to result in a lysate.

[0096] In one embodiment, a pre-prepared lysis solution or one or more lysis agents are added directly to the lysate obtained in step a). In this case, preferably no separation and / or removal of the first lysate comprising non-sperm DNA from the unlysed cells obtained from the first lysis step occurs.

[0097] In one embodiment, the cells not lysed in step c) are incubated in the lysis solution or with one or more lysis agents used in method step a). In a further embodiment, the cells not lysed in step c) are incubated in a lysis solution or with one or more lysis agents that is / are different in at least one agent and / or at least one concentration or amount of agent from that used in method step a).

[0098] In one embodiment of the description, the lysis solution applied in method step c) or one or more lysis agents is / are free of nuclease inhibiting agents, preferably free of chelating agents such as ethylenediaminetetraacetic acid (EDTA) and / or free of anionic detergents such as sodium dodecyl sulfate (SDS), sarcosyl deoxycholate, sodium lauryl ether sulfate (SLS), sodium octyl sulfate (SOS), sodium methyl cocoyl taurate and disodium coco sulfosuccinates, or any mixtures thereof.

[0099] After lysis step a) and / or c) the non-sperm DNA present in the first and / or second and / or additional lysate is broken down or separated or removed or separated and removed or broken down and removed or broken down, separated and removed from the first and / or second and / or lysate Petition 870250103223, dated 11 / 11 / 2025, page 133 / 182 / 71 additional including said non-sperm DNA.

[00100] The removal or separation of DNA, in particular non-sperm DNA, generally and particularly in step b) and / or d) can occur with any suitable means including precipitation, centrifugation, filtration, microbead separation, preferably magnetic microbead separation, binding to a non-particulate solid matrix, for example, a membrane or incubation with a nuclease.

[00101] In one embodiment of the description, the separation, removal, or separation and removal of unlysed cells occurs through centrifugation, preferably by forming a pellet of unlysed cells and / or sperm nuclei, through filtration, through binding to a solid matrix, preferably a membrane or microspheres, preferably magnetic microspheres.

[00102] In a preferred embodiment, the non-sperm DNA present in the first and / or second and / or additional lysate is digested or broken down using one or more nucleases.Preferably, one or more nucleases are selected from among nucleases comprising, for example, Turbonuclease, all members of the DNase I family, all members of the DNase II family, Micrococcus nuclease, Nuclease P1, Nuclease S1, Phosphodiesterase I, Phosphodiesterase II, Restriction Endonucleases, Salt-Activated Nuclease (SAN), RNase I, Turbo Nuclease (=Benzonase ®), BAL 31 Nuclease, Cold-Activated Cryonase Nuclease, Mung Bean Nuclease, Thermolabile Exonuclease I, Exonuclease Mst I, Exonuclease T, RecJf, T7 Exonuclease, RecBCD (Exonuclease V), truncated Exonuclease VIII, Lambda Exonuclease, T5 Exonuclease, DNase I-XT, DNaseMe, Saltonase, Masterase, Azotobacter nuclease, SM nuclease, Neurospora nuclease, Bacillus nucleases, Strptomycex Nucleases, C1 Nuclease, Yeast Nuclease, Leishmania Nuclease, Staphylococcal Nuclease, Bal 31 nuclease, Anabaena Nuclease, Lysobacter Nuclease, Vibrio Nuclease, Schizosaccharomyces Nuclease,. Petition 870250103223, dated 11 / 11 / 2025, p. 134 / 182 / 71 Nuclease Rsn, SR nuclease, Rye Germ Nuclease-I, Rye Germ Nuclease-II, Peunia Pollen Nuclease, Barley Nuclease, Wheat Nuclease, Potato Nuclease, Tobacco Pollen Nuclease, Barley Microspore Nuclease, Nuclease A, Drosophila Nuclease, Drosophila Embryo Nuclease, Shrimp Nuclease, Rat Liver Nuclease, Endonuclease G, Calf Thymus Nuclease, Phospholipase D Family, Caspase-activated DNase (CAD), DNase gamma (DNase γ), Msz Exonuclease I, Exonuclease I, Exonuclease II, Exonuclease III, Exonuclease IV, Exonuclease VI, Exonuclease VII, Exonuclease VIII, Exonuclease IX Exonuclease X, Cyclophilin, NUC-18 and Lactoferrin, more preferably a non-sperm cell digestion enzyme selected from the group consisting of proteinase K, protease, zymolase, lyticase, chromopeptidase, lysostaphin, lysozyme, nuclease, such as DNase, Benzonase(R), RNase, endonucleases and exonucleases; or any combination thereof.

[00103] In one embodiment, one or more nucleases are selected from among nucleases that have a large size, preferably 50 kDa or above, such as, for example, 60 kDa, 80 kDa, 100 kDa, 150 kDa, 200 kDa, 250 kDa, 300 kDa, 350 kDa, or preferably 400 kDa or above, such as nucleases having a size of 70 kDa, 90 kDa, 110 kDa, 120 kDa, 130 kDa, 140 kDa,160 kDa, 170 kDa, 180 kDa, 190 kDa, 210 kDa, 220 kDa, 230 kDa, 240 kDa, 260 kDa, 270 kDa, 280 kDa, 290 kDa, 310 kDa, 320 kDa, 330 kDa, 340 kDa, 360 kDa, 370 kDa, 380 kDa, 390 kDa, 410 kDa, 420 kDa, 430 kDa, 440 kDa, 450 kDa, 460 kDa, 470 kDa, 480 kDa, 490 kDa, or 500 kDa, or having any of the sizes in between.

[00104] In one embodiment, one or more nucleases are selected from among nucleases that have a large size, preferably above 50 kDa, such as the restriction endonuclease EcoR1, Phosphodiesterase I, Phosphodiesterase II, Exonuclease I, Exonuclease V (RecBCD), Exonuclease Petition 870250103223, dated 11 / 11 / 2025, page 135 / 182 / 71 VII, and Lactoferrin.

[00105] In a preferred embodiment, one or more nucleases are selected from among nucleases that do not or only moderately digest or decompose sperm DNA when it is still contained in sperm cells or sperm nuclei, but predominantly digest and / or decompose non-sperm DNA, such as are typically present together in forensic samples.

[00106] The present description also provides a nuclease that is particularly useful in the treatment of forensic samples comprising non-sperm DNA and sperm DNA together, where the objective is to digest and decompose non-sperm DNA without digesting or decomposing the sperm DNA present in the sperm cell, more specifically in the sperm nucleus of the sperm cell, from the same sample.

[00107] Currently, in workflows for isolating sperm DNA from samples containing both sperm cells and non-sperm cells, where non-sperm cells are usually in tremendous excess, such as in forensic samples and particularly sexual abuse samples, the nuclease used to digest non-sperm DNA (in particular DNase I) also digests sperm DNA to a great extent, even though the sperm DNA may still be within the sperm nucleus, i.e., before lysis of the sperm cell and / or sperm nucleus. This has the major disadvantage that, in attempting to reduce non-sperm DNA contamination in a forensic sample in order to improve the sensitivity of subsequent downstream analysis, the yield of sperm DNA may inadvertently be reduced, which in turn reduces sensitivity.Thus, in the known workflow in the state of the art, there is usually a conflict / competition between, on the one hand, reducing the amount of contaminating non-sperm DNA and, on the other hand, reducing the loss of sperm DNA, that is, obtaining a maximum yield of DNA. Petition 870250103223, dated 11 / 11 / 2025, page 136 / 182 / 71 sperm with minimal contamination of non-sperm DNA.

[00108] In another embodiment, one or more nucleases are selected from among nucleases that have multiple independent functions, such as helicase activity and / or endonuclease activity and / or exonuclease activity, preferably nucleases that have helicase activity and endonuclease activity, helicase activity and exonuclease activity, endonuclease and exonuclease activity, or helicase activity, endonuclease activity and exonuclease activity. The nuclease may preferably also recognize and be altered by the Chi DNA sequence.

[00109] Preferably nucleases that have helicase activity, endonuclease activity and exonuclease activity and the nuclease can also recognize and be altered by the Chi DNA sequence.

[00110] In another embodiment, one or more nucleases are selected from among nucleases that are large in size and have multiple independent functions, such as helicase activity and / or endonuclease activity and / or exonuclease activity.

[00111] In a preferred embodiment, one or more nucleases are selected from among nucleases having a size of 50 kDa or above, such as 60 kDa, 80 kDa, 100 kDa, 150 kDa, 200 kDa, 250 kDa, 300 kDa, 350 kDa, or preferably 400 kDa or above, such as having 70 kDa, 90 kDa, 110 kDa, 120 kDa, 130 kDa, 140 kDa, 160 kDa, 170 kDa, 180 kDa, 190 kDa, 210 kDa, 220 kDa, 230 kDa, 240 kDa, 260 kDa, 270 kDa, 280 kDa, 290 kDa, 310 kDa, 320 kDa, 330 kDa, 340 kDa, 360 kDa, 370 kDa, 380 kDa, 390 kDa, 410 kDa, 420 kDa, 430 kDa, 440 kDa, 450 kDa, 460 kDa, 470 kDa, 480 kDa, 490 kDa, or 500 kDa, or having any of the sizes between these, and in addition have multiple independent functions, such as a helicase activity, an endonuclease activity and / or an exonuclease activity. Petition 870250103223, dated 11 / 11 / 2025, page 137 / 182 / 71

[00112] In a preferred embodiment, one or more nucleases are selected from among nucleases that do not or only moderately digest or decompose sperm DNA while it is still contained in sperm cells or sperm nuclei, but predominantly digest and / or decompose non-sperm DNA, such as are typically present together in forensic samples.

[00113] Without being bound by any particular theory, it may be advantageous that nucleases desired for digesting non-sperm DNA, but not for digesting sperm DNA within sperm cells or sperm nuclei, be selected from large molecules that, due to their size, can be prevented from getting close to the sperm DNA, since this forms a cohesive, tightly packed formation like the sperm nucleus. Furthermore, in order for the nuclease to be able to exert endonuclease activity, it is assumed that first a segregation of the double-stranded DNA into single strands needs to occur. This can, for example, be achieved by a helicase, preferably by a nuclease that has helicase activity. However, this would be difficult with sperm DNA, since the sperm DNA is condensed within the sperm nucleus.It is consequently believed that due to the fact that sperm DNA is protected as a tightly packaged sperm nucleus, it is difficult for a small nuclease or a nuclease that has no exonuclease activity to scan and access the free starting points in the sperm DNA.

[00114] In one embodiment of the invention, the nuclease has at least one or more of the following features: i) it has a size of 50 kDa or more; ii) it has a size of 60 kDa, 80 kDa, 100 kDa, 150 kDa, 200 kDa, 250 kDa, 300 kDa, 350 kDa or preferably 400 kDa or Petition 870250103223, dated 11 / 11 / 2025, page 138 / 182 / 71 above, or any size in between; iii) it is selected from the group comprising restriction endonuclease EcoR1, Phosphodiesterase I, Phosphodiesterase II, Exonuclease I, Exonuclease V (RecBCD), Exonuclease VII, and Lactoferrin; iv) it has multiple independent functions; (v) it has helicase activity; vi) it has endonuclease activity; vii) it has exonuclease activity; viii) it has helicase activity and endonuclease activity; ix) it has helicase activity and exonuclease activity; x) it has endonuclease and exonuclease activity; xi) it has helicase activity, endonuclease activity, and exonuclease activity; xii) the nuclease is chosen so that it does not have access to the packaged DNA; xiii) the nuclease is chosen so that it digests and / or breaks down non-sperm DNA, but not sperm DNA; xiv) a nuclease can recognize and be altered by the Chi DNA sequence.

[00115] More specifically, Exonuclease V (RecBCD), which has a helicase and exonuclease activity, does not digest and / or decompose sperm DNA present in the sperm nucleus, but it does digest and / or decompose any other type of non-sperm DNA present in a sample. Exonuclease V (RecBCD) in particular can be used in methods, workflows, and kits for the treatment of forensic or sexual abuse samples comprising non-sperm cells and sperm cells, where selective isolation of sperm cell DNA that is essentially free is required. Petition 870250103223, dated 11 / 11 / 2025, page 139 / 182 / 71 of non-sperm cell DNA is paramount.

[00116] Separating the lysed and unlysed cell fractions after the first and / or second and / or additional lysis step, and thereby removing non-sperm DNA from sperm cells or sperm nuclei, reduces or removes contamination of sperm cells or sperm nuclei with non-sperm DNA before lysing the sperm fraction.

[00117] Once the non-sperm DNA is removed, the unlysed cell fraction is subjected to at least a third or additional lysis by applying a sperm cell and / or sperm nuclei lysis solution or one or more lysis agents capable of lysing sperm cells and / or sperm nuclei. A third or additional lysis comprises applying or treating the unlysed cells with the sperm cell and / or sperm nuclei lysis solution or one or more sperm cell and / or sperm nuclei lysis agents so as to lyse sperm cells and / or sperm nuclei and to form a third or additional lysate comprising sperm DNA.

[00118] The sperm cell and / or sperm nucleus lysis solution or one or more lysis agents comprise at least one sperm cell and / or sperm nucleus lysis agent selected from a reducing agent, a sperm cell and / or sperm nucleus lysis enzyme, a chaotropic agent and / or an alkaline agent at a concentration suitable for lysing sperm cells and / or sperm nuclei, or a combination thereof.

[00119] In one embodiment of the description, in method step (e) the sperm cell lysis solution or one or more sperm cell lysis agents is / are applied to non-lysed cells or sperm nuclei to form a third or additional lysate comprising sperm DNA.

[00120] In one type of description, in the method step e) a Petition 870250103223, dated 11 / 11 / 2025, page 140 / 182 / 71 sperm cell and / or sperm nucleus lysis solution or one or more sperm cell and / or sperm nucleus lysis agents is / are applied to non-lysed cells and / or sperm nuclei and the non-lysed cells and / or sperm nuclei are incubated in the sperm cell and / or sperm nucleus lysis solution or in one or more lysis agents to lyse sperm cells and / or sperm nuclei and to form a third or additional lysate comprising sperm DNA.

[00121] In the methods described herein, the sperm cell and / or sperm nucleus lysis solution or one or more sperm cell and / or sperm nucleus lysis agents comprise a chemical reducing agent. In some embodiments, the chemical reducing agent is selected from the group consisting of dithiothreitol (DTT), dithioerythrityl, β-mercaptoethanol (BME), glutathione (GSH), Tris(2-carboxyethyl)phosphine (TCEP), and combinations thereof. Any suitable amount of reducing agent may be added to the sperm provided that the concentration of the reducing agent is sufficient to break the disulfide bonds present in the sperm cells and sperm nuclei. In certain embodiments, the concentration of the chemical reducing agent is between 0.1 mM and 0.1 M (calculated within the total lysate).

[00122] In one embodiment of the present description, the sperm cell and / or sperm nucleus lysis solution or one or more sperm cell and / or sperm nucleus lysis agents comprise(s) at least one agent selected from sperm-digesting enzymes, such as trypsin.

[00123] In a preferred embodiment, the sperm cell and / or sperm nucleus lysis solution or one or more sperm cell and / or sperm nucleus lysis agents further comprise a chaotropic compound. The chaotropic compound is preferably a guanidinium salt, preferably selected from the group comprising Petition 870250103223, dated 11 / 11 / 2025, p. 141 / 182 / 71 guanidinium hydrochloride, guanidinium thiocyanate and / or guanidinium isothiocyanate or mixtures thereof. Preferably, the total concentration of the chaotropic compound(s) in the lysis solution or one or more lysis agents is in the range of > 0.005 mM to < 8 M, more preferably in a range of > 1 M to < 5 M based on the total volume of the lysis solution or total lysate.

[00124] In one embodiment of the present description, the sperm cell and / or sperm nucleus lysis solution or one or more sperm cell and / or sperm nucleus lysis agents comprise(s) at least one chemical reducing agent and at least one enzyme that digests sperm cells.

[00125] In one embodiment of the present description, sperm cells and / or sperm nuclei are subjected to alkaline lysis. Preferably, the alkaline conditions are established using hydroxide salts such as NaOH, KOH or similar. The hydroxide concentration in the lysis mixture should be in the range of 10 mM to 1 M, preferably 25 mM to 800 mM, more preferably 50 mM to 600 mM, additionally preferred 250 to 400 mM.

[00126] In certain embodiments, the method described additionally includes, after method step b) and / or d), at least one washing step of the unlysed cells or cell pellet. Preferably, the unlysed cell pellet is thus resuspended in a suitable washing composition at room temperature, subsequently centrifuged, preferably at 15,000 x g for 5 minutes, and the supernatant is finally discarded.

[00127] In a preferred embodiment, the washing composition is selected from the group consisting of water or the lysis solution, or any combination thereof.

[00128] In a preferred embodiment, the washing composition is Petition 870250103223, dated 11 / 11 / 2025, pp. 142 / 182 / 71 applied at room temperature.

[00129] In a preferred embodiment, the washing composition comprises a chaotropic agent having a concentration in the range of > 0.1 M to < 3.5 M, particularly preferably in the range of > 0.4 M to < 3 M based on the total volume of the buffer composition.

[00130] In one embodiment of the description, the lysis step e) is repeated once, twice, or several times to ensure complete lysis of sperm cells and sperm nuclei.

[00131] In one embodiment of the description, the first, second, third, or any additional lysis is performed at room temperature or at a temperature sufficient to ensure efficient lysis of the cells and nuclei. In a preferred embodiment, the lysis is performed at a temperature in the range of 30°C to 80°C, preferably between 37°C and 75°C, more preferably at 37°C, 56°C, 70°C, 75°C, and / or 80°C.

[00132] The present description also provides kits for the treatment of forensic specimens comprising non-sperm cells and sperm cells and sperm nuclei comprising one or more of a) a first non-sperm cell lysis solution or one or more non-sperm cell lysis agents capable of lysing non-sperm cells and essentially unsuitable for completely lysing sperm cells or sperm nuclei, b) a second non-sperm cell lysis solution or one or more non-sperm cell lysis agents capable of lysing non-sperm cells and essentially unsuitable for completely lysing sperm cells and sperm nuclei, wherein the second non-sperm cell lysis solution or the one or more non-sperm cell lysis agents are identical to the first non-sperm cell lysis solution or the one or more non-sperm cell lysis agents used in a),or in which the second non-sperm cell lysis solution or one or more non-sperm cell lysis agents are, Petition 870250103223, dated 11 / 11 / 2025, page 143 / 182 / 71 different from the first non-sperm cell lysis solution or one or more non-sperm cell lysis agents used in a).

[00133] The present description also provides a method for the treatment of a biological sample comprising sperm cells and / or sperm nuclei and non-sperm cells, the method comprising: i. subjecting the biological sample comprising sperm cells and / or sperm nuclei and non-sperm cells to lysis by applying one or more lysis agents or a lysis solution to the biological sample and / or incubating the biological sample with one or more lysis agents or in the lysis solution, wherein the one or more lysis agents or the lysis solution are suitable for essentially lysing the non-sperm cells and for forming a first lysate comprising non-sperm DNA, sperm cells and / or sperm nuclei, wherein the one or more lysis agents or the lysis solution do not comprise any agent in an amount that causes complete lysis of sperm cells and / or sperm nuclei and preferably comprise at least one agent selected from a surfactant, a chaotropic agent, a non-sperm cell digestion enzyme, or any combination thereof; ii. decompose most or all of the non-sperm DNA obtained from the lysate in step a) using an enzyme having both helicase and exonuclease activity and / or having a size greater than 50 kDa while not decomposing or not significantly decomposing the sperm DNA; and iii. subject the unlysed cells to a second lysis, applying a sperm cell and / or sperm nucleus lysis solution or one or more lysis agents to completely lyse sperm cells and / or sperm nuclei and to form a third or additional lysate comprising sperm DNA, wherein the sperm cell and / or sperm nucleus lysis solution or one or more lysis agents Petition 870250103223, dated 11 / 11 / 2025, page 144 / 182 / 71 comprise at least one sperm cell and / or sperm nucleus lysis agent selected from a reducing agent, a sperm cell and / or sperm nucleus lysis enzyme, a chaotropic agent at a concentration suitable for lysing a sperm cell and / or sperm nuclei and / or an alkaline agent at a concentration suitable for lysing sperm cells and / or sperm nuclei or a combination thereof.

[00134] It has been surprisingly shown that an enzyme having a helicase and an exonuclease activity and / or having a size above 50 kDa, which is preferably RecBCD, is suitable for completely or at least predominantly decomposing non-sperm DNA in a sample comprising non-sperm DNA and sperm DNA while not or only or only moderately, markedly or slightly decomposing sperm DNA that is still contained in the nuclei.

[00135] “Not significantly decompose sperm DNA” is supposed to indicate that although desirable, it is not necessary that absolutely no sperm DNA be decomposed, but rather that it cannot be excluded that a small amount of sperm DNA may also be decomposed when using an enzyme such as RecBCD.

[00136] In one embodiment, that no pronounced sperm DNA breakdown occurs can be determined by the DNA degradation ratio of the male DNA (as defined, for example, in the QIAGEN DNA Investigator Quantiplex Pro RGQ Kit). In one embodiment, said ratio should be < 1.5, preferably < 1.4, preferably < 1.3, more preferably < 1.2, even more preferably < 1.1, and most preferably 1 or below. An additionally suitable indicator of non-pronounced sperm DNA breakdown is the amount by which the sperm DNA is reduced. In one embodiment, no more than 50% of the sperm DNA, preferably no more than 40%, more preferably no more than Petition 870250103223, dated 11 / 11 / 2025, pp. 145 / 182 / 71 30%, even more preferably no more than 20%, in particular no more than 10%, preferably no more than 5%, more preferably no more than 3%, and most preferably no more than 1% of sperm DNA is broken down compared to the amount of sperm DNA contained in the sperm nuclei before enzymatic digestion.

[00137] “Decomposing most of the non-sperm DNA” is supposed to mean that the non-sperm DNA is reduced by at least 70%, preferably by at least 80%, more preferably by at least 85%, more preferably by at least 90%, even more preferably by at least 95%, most preferably by at least 98% during enzymatic digestion compared with the amount present before said digestion.

[00138] Smaller nucleases or nucleases not having any combination of functionalities such as a helicase and an exonuclease functionality, for example, DNase I, are commonly used to decompose contaminating non-sperm DNA in samples comprising non-sperm DNA and sperm DNA, such as in forensic samples and in particular samples obtained after sexual abuse offenses. However, when using such nucleases as DNase I, they not only decompose the non-sperm DNA released from cells in a lysis process, but also decompose the target sperm DNA in such samples, even if the sperm DNA is still retained in the nucleus and not yet released and thus not directly accessible.Consequently, although a selective lysis procedure is used to selectively lyse primarily non-sperm cells in order to allow separation of excess non-sperm DNA from the target sperm DNA, in attempting to remove the contaminating non-sperm DNA by enzymatic decomposition, the sperm DNA within the sperm nuclei is also decomposed, which tremendously reduces the yield of sperm DNA obtained using such a procedure. Petition 870250103223, dated 11 / 11 / 2025, pp. 146 / 182 / 71

[00139] Consequently, while a procedure such as described above in which a selective non-sperm cell lysis procedure is conducted at least twice is still superior, notwithstanding the use of the enzymes specified above with a combination of functionalities and / or a size above 50 kDa to decompose non-sperm DNA even with the conduct of only one non-sperm cell lysis procedure, the yield and quality of sperm DNA that is isolated after such a procedure is markedly better than when using commonly used state-of-the-art enzymes such as DNase I under such conditions.

[00140] In one embodiment, one or more nucleases are selected from among nucleases that have a large size, preferably 50 kDa or above, such as, for example, 60 kDa, 80 kDa, 100 kDa, 150 kDa, 200 kDa, 250 kDa, 300 kDa, 350 kDa, or preferably 400 kDa or above, such as nucleases having a size of 70 kDa, 90 kDa, 110 kDa, 120 kDa, 130 kDa, 140 kDa, 160 kDa, 170 kDa, 180 kDa, 190 kDa, 210 kDa, 220 kDa, 230 kDa, 240 kDa, 260 kDa, 270 kDa, 280 kDa, 290 kDa, 310 kDa, 320 kDa, 330 kDa, 340 kDa, 360 kDa, 370 kDa, 380 kDa, 390 kDa, 410 kDa, 420 kDa, 430 kDa, 440 kDa, 450 kDa, 460 kDa, 470 kDa, 480 kDa, 490 kDa, or 500 kDa, or having any of the sizes in between.

[00141] In one embodiment, one or more nucleases are selected from among nucleases that have a larger size, preferably above 50 kDa, such as the restriction endonuclease EcoR1, Phosphodiesterase I, Phosphodiesterase II, Exonuclease I, Exonuclease V (RecBCD), Exonuclease VII, and Lactoferrin.

[00142] In a preferred embodiment, one or more nucleases are selected from among nucleases that do not digest or decompose, or only moderately digest, sperm DNA while it is still contained in sperm cells or sperm nuclei, but predominantly digest and / or Petition 870250103223, dated 11 / 11 / 2025, page 147 / 182 / 71 decompose non-sperm DNA, as they are typically present together in forensic samples.

[00143] In another embodiment, one or more nucleases are selected from among nucleases that have multiple independent functions, such as helicase activity and exonuclease activity, optionally additionally endonuclease activity. The nuclease may also preferably recognize and be altered by the Chi DNA sequence.

[00144] Preferably, nucleases have helicase activity, endonuclease activity, and exonuclease activity, and in addition, the nuclease can also recognize and be altered by the Chi DNA sequence.

[00145] In another embodiment, one or more nucleases are selected from among nucleases that are large in size and have multiple independent functions, such as helicase activity and / or endonuclease activity and / or exonuclease activity.

[00146] Without being bound by any particular theory, it may be advantageous that nucleases desired to digest non-sperm DNA, but not sperm DNA within sperm cells or sperm nuclei, be selected from large molecules that, due to their size, can be prevented from getting close to the sperm DNA, since this forms a cohesive, tightly packed formation like the sperm nucleus. Furthermore, in order for the nuclease to be able to exert endonuclease activity, it is assumed that first a segregation of the double-stranded DNA into single strands needs to occur. This can, for example, be achieved by a helicase, preferably by a nuclease that has helicase activity. However, this would be difficult with sperm DNA, since sperm DNA is condensed within the sperm nucleus. It is consequently believed that due to the fact that sperm DNA is protected as a Petition 870250103223, dated 11 / 11 / 2025, page 148 / 182 / 71 tightly packed sperm nucleus, it is difficult for a small nuclease or a nuclease that has no exonuclease activity to check and access the free starting points in the sperm DNA.

[00147] In one embodiment of the invention, the nuclease has at least one or more of the following features: i) it has a size of 50 kDa or more; ii) it has a size of 60 kDa, 80 kDa, 100 kDa, 150 kDa, 200 kDa, 250 kDa, 300 kDa, 350 kDa or preferably 400 kDa or above, or any size in between; iii) it is selected from the group comprising restriction endonuclease EcoR1, Phosphodiesterase I, Phosphodiesterase II, Exonuclease I, Exonuclease V (RecBCD), Exonuclease VII and Lactoferrin; iv) it has multiple independent functions; (v) it has helicase activity; vi) it has endonuclease activity; vii) it has exonuclease activity; viii) it has helicase activity and exonuclease activity; ix) it has helicase activity, endonuclease activity, and exonuclease activity; x) the nuclease is chosen so that it does not have access to the packaged DNA; xi) the nuclease is chosen so that it digests and / or breaks down non-sperm DNA, but not sperm DNA; xii) the nuclease can recognize and be altered by the Chi DNA sequence.

[00148] More specifically, Exonuclease V (RecBCD), which has both helicase and exonuclease activity, does not digest and / or decompose sperm DNA while it is present in the sperm nucleus, but it does digest and / or Petition 870250103223, dated 11 / 11 / 2025, pp. 149 / 182 / 71 decompose any other type of non-sperm DNA present in a sample. Exonuclease V (RecBCD) in particular can be used in methods, workflows and kits for the treatment of forensic or sexual abuse samples comprising non-sperm cells and sperm cells, where selective isolation of sperm cell DNA that is essentially free of non-sperm cell DNA is paramount.

[00149] The present description also provides the use of an enzyme having exonuclease and helicase activity and / or a nuclease having a size above 50 kDa for the decomposition of non-sperm DNA in a sample comprising a mixture of non-sperm DNA and sperm DNA, the sperm DNA being contained in sperm cells and / or sperm nuclei. Such a mixture of non-sperm DNA and sperm DNA, the sperm DNA being contained in sperm cells and / or sperm nuclei, is usually part of the treatment and analysis of a forensic sample, in particular a sample obtained after a sexual abuse offense. Preferably, RecBCD is used for the decomposition of non-sperm DNA in such mixtures.

[00150] In one embodiment, one or more nucleases are selected from among nucleases that have a large size, preferably 50 kDa or above, such as, for example, 60 kDa, 80 kDa, 100 kDa, 150 kDa, 200 kDa, 250 kDa, 300 kDa, 350 kDa, or preferably 400 kDa or above, such as nucleases having a size of 70 kDa, 90 kDa, 110 kDa, 120 kDa, 130 kDa, 140 kDa, 160 kDa, 170 kDa, 180 kDa, 190 kDa, 210 kDa, 220 kDa, 230 kDa, 240 kDa, 260 kDa, 270 kDa, 280 kDa, 290 kDa, 310 kDa, 320 kDa, 330 kDa, 340 kDa, 360 kDa, 370 kDa, 380 kDa, 390 kDa, 410 kDa, 420 kDa, 430 kDa, 440 kDa, 450 kDa, 460 kDa, 470 kDa, 480 kDa, 490 kDa, or 500 kDa, or having any of the sizes in between.

[00151] In one embodiment, one or more nucleases are selected from among nucleases that have a large size, preferably above Petition 870250103223, dated 11 / 11 / 2025, pp. 150 / 182 / 71 kDa, such as the restriction endonuclease EcoRi, Phosphodiesterase I, Phosphodiesterase II, Exonuclease I, Exonuclease V (RecBCD), Exonuclease VII, and Lactoferrin.

[00152] In a preferred embodiment, one or more nucleases are selected from among nucleases that do not digest or decompose, or only moderately, sperm DNA when it is still contained in sperm cells or sperm nuclei, but predominantly digest and / or decompose non-sperm DNA, such as is typically present together in forensic samples.

[00153] In another embodiment, one or more nucleases are selected from among nucleases that have multiple independent functions, such as helicase activity and exonuclease activity, optionally additionally endonuclease activity. The nuclease may preferably also recognize and be altered by the Chi DNA sequence.

[00154] Preferably, nucleases have helicase activity, endonuclease activity, and exonuclease activity, and the nuclease can also recognize and be altered by the Chi DNA sequence.

[00155] Without being bound by any particular theory, it may be advantageous that nucleases that are desired to digest non-sperm DNA, but not sperm DNA within sperm cells or sperm nuclei, be selected from large molecules that, due to their size, can be prevented from getting close to the sperm DNA, since this forms a cohesive, tightly packed formation like the sperm nucleus. Furthermore, in order for the nuclease to be able to exert endonuclease activity, it is assumed that first a segregation of the double-stranded DNA into single strands needs to occur. This can, for example, be achieved by a Petition 870250103223, dated 11 / 11 / 2025, p. 151 / 182 / 71 helicase, preferably by a nuclease having helicase activity. However, this would be difficult with sperm DNA, since sperm DNA is condensed within the sperm nucleus. It is consequently believed that due to the fact that sperm DNA is protected as a tightly packed sperm nucleus, it is difficult for a small nuclease or a nuclease that does not have any exonuclease activity to scan and access the free starting points in the sperm DNA.

[00156] In one embodiment of the invention, the nuclease has at least one of the following features: i) it has a size of 50 kDa or greater; ii) it has a size of 60 kDa, 80 kDa, 100 kDa, 150 kDa, 200 kDa, 250 kDa, 300 kDa, 350 kDa or preferably 400 kDa or above, or any size in between; iii) it is selected from the group comprising restriction endonuclease EcoR1, Phosphodiesterase I, Phosphodiesterase II, Exonuclease I, Exonuclease V (RecBCD), Exonuclease VII and Lactoferrin; iv) it has multiple independent functions; (v) it has helicase activity; vi) it has endonuclease activity; vii) it has exonuclease activity; viii) it has helicase activity and exonuclease activity; ix) it has helicase activity, endonuclease activity, and exonuclease activity; x) the nuclease is chosen so that it does not have access to the packaged DNA; xi) the nuclease is chosen so that it digests and / or breaks down non-sperm DNA, but not sperm DNA; Petition 870250103223, dated 11 / 11 / 2025, pp. 152 / 182 / 71 xii) the nuclease can recognize and be altered by the Chi DNA sequence.

[00157] More specifically, Exonuclease V (RecBCD), which has both helicase and exonuclease activity, does not digest and / or decompose sperm DNA while it is present in the sperm nucleus, but it does digest and / or decompose any other type of non-sperm DNA present in a sample. Exonuclease V (RecBCD) in particular can be used in methods, workflows, and kits for the treatment of forensic or sexual abuse samples comprising non-sperm cells and sperm cells, where selective isolation of sperm cell DNA that is essentially free of non-sperm cell DNA is paramount.

[00158] For further specification of the conditions and characteristics of the resources specified in steps i) to iii) of the method and of the enzyme and / or nuclease in the indicated use, the statements and information in the specification above that are analogously applicable should be consulted, in particular the specification describing resources a), b), d) and e) above.

[00159] This description provides kits for the treatment of biological samples, such as forensic samples, comprising non-sperm cells and sperm cells, the kit comprising one or more of: a) a first non-sperm cell lysis solution or one or more non-sperm cell lysis agents capable of lysing non-sperm cells and essentially unsuitable for completely lysing sperm cells and / or sperm nuclei; (b) a second non-sperm cell lysis solution and / or an additional or one or more non-sperm cell lysis agents capable of lysing non-sperm cells but not suitable for completely lysing sperm cells and / or sperm nuclei, wherein the second non-sperm cell lysis solution and / or an additional or one or more non-sperm cell lysis agents is / are identical to the first. Petition 870250103223, dated 11 / 11 / 2025, page 153 / 182 / 71 non-sperm cell lysis solution or one or more non-sperm cell lysis agents used in a), or wherein the second non-sperm cell lysis solution and / or an additional one or more non-sperm cell lysis agents is / are different from the first non-sperm cell lysis solution or one or more non-sperm cell lysis agents used in a); c) optionally, one or more washing compositions; d) optionally one or more DNA digestion enzymes; (e) a solution for lysing sperm cells and / or sperm nuclei or one or more sperm cell and / or sperm nucleus lysis agents capable of lysing sperm cells and / or sperm nuclei, preferably the lysis solution or one or more sperm cell and / or sperm nucleus lysis agents comprising at least one reducing agent selected from the group consisting of dithiothreitol (DTT), dithioerythrityl, β-mercaptoethanol (BME), glutathione (GSH), Tris(2-carboxyethyl)phosphine (TCEP) and combinations thereof; a sperm lysing enzyme selected from the group consisting of proteinase K, protease, zymolase, lyticase, chromopeptidase, trypsin, lysostaphin, lysozyme and / or combinations thereof; a chaotropic agent and / or an alkaline agent at a concentration suitable for lysing a sperm cell and / or sperm nuclei; or any combination thereof.

[00160] The first, second and / or additional non-sperm lysis solutions or one or more non-sperm cell lysis agents and / or sperm cell and / or sperm nuclei lysis solutions or one or more sperm cell and / or sperm nuclei lysis agents as well as the washing compositions used in the kits of the description are described in detail above and also apply to this aspect of the description.

[00161] The first, second and / or additional lysis solution and / or the sperm cell and / or sperm nucleus lysis solutions present in Petition 870250103223, dated 11 / 11 / 2025, page 154 / 182 / 71 kits may be provided as ready-to-use mixtures or as separate components or compositions to be mixed (before use) or added directly to the material to be lysed by the user in accordance with the instructions in the kit. The lysis solutions and / or their individual agents or compositions are provided in suitable containers.

[00162] In one embodiment, the kit additionally comprises containers, collection tubes, sample tubes, etc., rotating columns or baskets, and other useful material suitable for sample processing according to the method described. The kit also includes instructions for use.

[00163] In some embodiments, the present description includes an apparatus for processing a forensic sample including sperm cells and sperm nuclei and non-sperm cells. The method can be easily adapted for automation and low or high throughput processing with a robotic system.

[00164] In one embodiment, the method described further comprises purifying, isolating, detecting, analyzing and / or quantifying non-sperm cells and / or sperm DNA.

[00165] In some modalities, sperm DNA is obtained from the purified sperm fraction and further analyzed. For example, sperm DNA can be quantified or genotyped.

[00166] In an additional embodiment, the non-sperm DNA obtained from the sample is further purified and / or analyzed. For example, the non-sperm DNA can be quantified or genotyped.

[00167] Methods for quantifying DNA are known in the art and include, for example, spectrophotometry, fluorescence, real-time PCR (also known as quantitative PCR (qPCR)), and digital PCR technologies. DNA genotyping can be performed using any suitable method known in the art. Such methods include, for example, short tandem repeat (STR) analysis, length polymorphism. Petition 870250103223, dated 11 / 11 / 2025, page 155 / 182 / 71 of restriction fragment length (RFLP) of genomic DNA, random amplified polymorphic detection (RAPD) of genomic DNA, amplified fragment length polymorphism (AFLP) detection, single nucleotide polymorphism (SNP) detection, polymerase chain reaction (PCR), DNA sequencing, allele-specific oligonucleotide (ASO) probes, and hybridization to DNA microarrays or microspheres. EXAMPLES:

[00168] Each example is provided for explanation of the description and is not intended as a limitation of the description. Example 1

[00169] This example demonstrates that a considerable fraction of epithelial cells remain intact if subjected to only one lysis step. When subjected to a subsequent lysis step, these intact epithelial cells are lysed and additional DNA is released. The yield of DNA isolated from epithelial cells after a first lysis and a second subsequent lysis is shown in Figure 1. An extract of the STR profiles of the isolated DNA is shown in Figure 2.

[00170] Vaginal swabs containing epithelial cells (but no sperm cells) were subjected to a first lysis step where the vaginal swab samples were mixed with 500 pL of a lysis buffer comprising 0.3% SDS and 25 pL Proteinase K (QIAGEN) and incubated at 56°C for one hour at 900 rpm and then at 80°C for 10 min. The samples were then transferred to a spinning basket (e.g., the QIAshredder-spin basket - QIAGEN) and centrifuged at maximum speed (15,000 rpm) for approximately 5 minutes, whereby a pellet comprising intact (non-lysed) cells was obtained. Most of the lysed “supernatant” was removed by pipetting and the DNA present in the “supernatant” fraction was purified using the workflow of the EZ1&2 DNA Investigator Kit (QIAGEN). Petition 870250103223, dated 11 / 11 / 2025, pp. 156 / 182 / 71

[00171] The cell pellet from intact / non-lysed cells and the remaining traces of the first lysate that could not be removed without disturbing the pellet (approximately 30 pl) were subjected to digestion with DNase I at 40°C for approximately 15 min to remove (digest) any DNA present in the remaining lysate and contaminating the cell pellet.

[00172] A 50 pL aliquot of the liquid mixture after digestion with DNase was removed and the DNA present in said “after digestion with DNase” fraction was purified using the workflow of the EZ1&2 DNA Investigator Kit (QIAGEN).

[00173] In the remaining mixture after digestion with DNase containing liquid and cells, the DNase enzyme was inactivated by subjecting said mixture to heat treatment at 80°C for approximately 5 min.

[00174] After the enzyme was inactivated, the said mixture comprising the intact (non-lysed) cells was subjected to a second lysis.

[00175] For the second lysis, the mixture comprising the intact (non-lysed) cells was mixed with a lysis buffer comprising 0.5% SDS and 1% chaotropic salts and 25 pL Proteinase K (QIAGEN) and incubated at 56°C for approximately one hour. The DNA present in the “2-lysis” fraction was purified using the EZ1&2 DNA Investigator workflow (QIAGEN).

[00176] Following purification, the DNA samples were quantified by qPCR in a PCR thermocycler (7500 Real-Time Systems from Applied Biosystems using the “Investigator Quantiplex Pro Kit” (QIAGEN Cat. No. / ID: 387216). A maximum of 15 pL of eluate was used for PCR with the QIAGEN Investigator 24plex QS Kit (Cat. No. / ID: 382415). The amplified DNA was analyzed by capillary electrophoresis. For the analysis, the samples are diluted to a maximum of 500 pg input and applied to the CE (ABI PRISM Genetic Analyzer 3500 XL). Petition 870250103223, dated 11 / 11 / 2025, pp. 157 / 182 / 71

[00177] The results are shown in Figures 1 and 2.

[00178] With reference to Figure 1, the three columns show the amount of DNA isolated from a female cell sample after the sample underwent a first lysis (“supernatant”), after digestion with DNase, and after a second lysis (“2-lysis”) of the sample. Parts A and B show the same data, but the DNA yield is plotted on a logarithmic scale (A) or a linear scale with a broken Y-axis (B). The linear scale better illustrates the tremendous reduction in the amount of autosomal DNA in the sample after digestion and 2-lysis compared to the amount in the supernatant (from 1901.5 ng to 0.007 ng and 0.539 ng, respectively), which is more realistically shown in absolute numbers on the linear scale than on the logarithmic scale. The yield of autosomal DNA was calculated for 470 pL of the “supernatant” sample and for 50 pL aliquots of the digested samples (“after digestion with DNase”) and the samples lysed twice (“2-lysis”).

[00179] Figure 1 (A&B) shows that most of the vaginal cells in the sample were lysed during the first lysis step. Consequently, there is a high amount of DNA in the supernatant. The amount of DNA detected in the mixture after digestion with DNase (which is only slightly above the detection limit of about 0.001 ng) shows that before the second lysis occurred, the mixture containing liquid and intact / non-lysed cells contained almost no DNA. Surprisingly, after the second lysis step, a considerable amount of DNA could still be detected, although it was lower than the amount of DNA contained in the supernatant after the first lysis.

[00180] The DNA quantified in the “2nd lysis” mixture is expected to result from cells that were not lysed during the first lysis and that were obtained in addition to the “supernatant”. Digestion of the DNA from the remaining mixture from the first lysis, after removing the supernatant, removes free DNA that Petition 870250103223, dated 11 / 11 / 2025, pp. 158 / 182 / 71 could be present in the remaining traces of the first lysate or cell fragment. Only a minuscule amount of DNA could be quantified in the supernatant after digestion with DNase (see Fig. 1, plotted on a logarithmic scale). The DNA detected after the second lysis is consequently assumed to originate from epithelial cells that were not lysed in the initial / primary lysis of the cell sample, but surprisingly remained intact.

[00181] This example shows that the first lysis step does not result in complete lysis of vaginal cells. Instead, enough cells remain that, if not removed in a second or additional lysis procedure, they are supposed to contaminate other cells of interest, such as sperm cells and sperm nuclei in sexual abuse samples, and will result in sperm DNA contamination with female cell DNA when the sperm cells and nuclei are lysed in the presence of vaginal cells.

[00182] The results of the STR analysis are shown in Figure 2.0

[00183] The DNA isolated from the three fractions obtained as explained above was amplified and the STR profiles of the DNA obtained from the “supernatant” fraction, the “after DNase digestion” fraction, and the “2-lysis” fraction were determined. Each sample was diluted to a 500 pg entry and subjected to capillary electrophoresis (CE) on an ABI PRISM Genetic Analyzer 3500 XL, and the STR alleles of the violet channel were used for identification as outlined in Table 1. Table 1: STR allele (purple channel extract)______ QS1 Q D16S539 11 12 CSF1PO 12 13 D13S317 12 D5S818 12 D7S820 10 12 QS2 S

[00184] The “supernatant” graph shows all the alleles of the reference DNA profile in the violet channel.

[00185] The graph “after digestion with DNase” does not show Petition 870250103223, dated 11 / 11 / 2025, page 159 / 182 / 71 no allele because the DNA digestion of the mixture obtained from the first lysis after removing the supernatant was successful and any amount of free DNA remaining in the lysed sample was too low to be detected during STR analysis.

[00186] The “after 2-analysis” graph shows the same allele profiles in the violet channel as the “supernatant” graph. This shows that the DNA was not contaminated by foreign DNA and originated from the same person as the “supernatant” sample. Example 2

[00187] This example shows the purity of DNA associated with sperm isolated from simulated samples (ejaculate found on vaginal swabs) if the non-sperm cells in the sample were subjected to lysis once (1-lysis) and twice (1a + 2-lysis). The yield of isolated DNA is shown in Figures 3a and 3b. The STR profiles are shown in Figure 4. Workflow with 1 lysis step for non-sperm cells: Lysis of non-sperm cells

[00188] Vaginal swabs (treated under the same conditions and forming Sample 1 and Sample 2) containing epithelial cells were enriched with ejaculate (Sample 1 contained 0.0007% sperm, Sample 2 contained 0.0006% sperm) and subjected to a first lysis step under conditions whereby non-sperm cells are lysed, but not sperm cells or sperm nuclei. The samples were mixed with 500 pL of a lysis buffer comprising 0.1% SDS and 25 pL Proteinase K (QIAGEN) and incubated at 56°C for one hour at 900 rpm. The samples were swirled, transferred to a spinning basket (e.g., QIAshredder-spin basket - QIAGEN), and centrifuged at maximum speed (15,000 rpm) for approximately 5 minutes, resulting in a pellet containing the unlysed (intact) cells. Most of the lysed "supernatant" was removed by pipetting. Petition 870250103223, dated 11 / 11 / 2025, pp. 160 / 182 / 71 and the DNA present in the “non-sperm” fraction was purified using the workflow of the EZ1&2 DNA Investigator Kit (QIAGEN). The amount of DNA recovered is shown in Figure 3a (non-sperm fraction - Sample 1 and Sample 2).

[00189] The remaining traces of the first lysate that could not be removed without disturbing the pellet (approximately 30 μl) and the cell pellet / nuclei were then subjected to digestion with DNase I at 40°C for approximately 15 min in order to remove any DNA present in the remaining lysate and contaminating the pellet. Sperm lysis of the sperm fraction (SF)

[00190] For the lysis of sperm cells and sperm nuclei, the mixture after digestion with DNase comprising liquid and still intact sperm cells and nuclei (referred to in Figures 3b and 4 as the “sperm fraction”) was first mixed with 408 μL of a 2.5 M chaotropic buffer to stop the remaining DNase activity. Subsequently, 4.5 μL of a 1 M TCEP (tris(2-carboxyethyl)phosphine) solution was added to the resulting mixture containing the sperm cells and nuclei and any remaining non-sperm cells and incubated at 25°C for 15 min and 900 rpm. Under these conditions, the remaining cells and nuclei are completely lysed to obtain the sperm (or male) DNA and any contaminating non-sperm (female) DNA.

[00191] The DNA (sperm DNA and non-sperm cell residual DNA) was then purified using the QIAGEN EZ2 DNA Investigator sexual abuse workflow (QIAGEN). The amount of DNA recovered is shown in Figure 3b (sperm fraction - Sample 1 and Sample 2). Workflow with 1a+ 2 analysis of non-sperm cells 1aLysis of non-sperm cells Petition 870250103223, dated 11 / 11 / 2025, pages 161 / 182 / 71

[00192] Vaginal swabs (treated under the same conditions and forming Sample 3 and Sample 4) containing epithelial cells were enriched with ejaculate (Sample 3 contained 0.0007% sperm, Sample 4 contained 0.0006% sperm) and subjected to a first lysis step under conditions whereby non-sperm cells are lysed, but not sperm cells or sperm nuclei. The samples were mixed with 500 gL of a lysis buffer comprising 0.1% SDS and 25 gL Proteinase K and incubated at 56°C for one hour at 900 rpm. The samples were swirled, then transferred to a spinning basket (e.g., QIAshredder-spin basket - QIAGEN) and centrifuged at maximum speed (15,000 rpm) for about 5 minutes, resulting in a pellet comprising the unlysed (intact) cells.

[00193] Most of the lysed “supernatant” was removed by pipetting and the DNA was purified using the workflow of the EZ1&2 DNA Investigator Kit (QIAGEN). The amount of DNA recovered is shown in Figure 3a (non-sperm fraction - Sample 3 and Sample 4). 2aLysis of non-sperm cells

[00194] The sample (remnants of the first lysate that could not be removed without disturbing the pellet (approximately 30 g / L) and intact cells) was subjected to a second lysis under conditions whereby non-sperm cells are lysed, but not sperm cells or sperm nuclei. This was achieved by mixing the sample with a lysis buffer comprising 1% Tween20 and 25 g / L Proteinase K (QIAGEN) and incubating at 60°C for 25 min at 900 rpm and then at 80°C for 5 min.

[00195] The mixture obtained from the second lysis, containing the supernatant as well as the still intact cells and nuclei, was then subjected to digestion with DNase I at 40°C for approximately 15 min in order to remove Petition 870250103223, dated 11 / 11 / 2025, pages 162 / 182 / 71 any DNA present in the lysate.

[00196] Alternatively, the remaining non-sperm cell DNA can be digested using an alternative nuclease such as Benzonase, all other members of the DNase I family, Exonuclease V (RecBCD), DNaseMe, Masterase, Saltonase, a combination of at least one restriction endonuclease and Nuclease S1 or Exonuclease III, or both. Adjustments to the second lysis buffer would be necessary. Sperm lysis

[00197] For the lysis of sperm cells and sperm nuclei, the sample (the mixture from the second lysis after digestion with DNase comprising liquid and still intact cells) was first mixed with 408 pL of a 2.5 M chaotropic buffer to stop the remaining DNase activity. Subsequently, 4.5 pL of a 1M TCEP (tris(2-carboxyethyl)phosphine) solution were added to the sample fraction containing the sperm cells and nuclei and incubated for 15 min at 25°C and 900 rpm. Under these conditions, the sperm cells are lysed, and the resulting lysate contains sperm DNA.

[00198] The DNA was purified using the QIAGEN EZ2 DNA Investigator (QIAGEN) sexual abuse workflow. The amount of DNA recovered is shown in Figure 3b (sperm fraction - Sample 3 and Sample 4). Quantification and analysis of STR

[00199] DNA samples were quantified by qPCR in a PCR thermocycler (Applied Biosystems 7500 Real-Time Systems) using the “Investigator Quantiplex Pro Kit” (QIAGEN Cat. No. / ID: 387216). STR-PCR was conducted with the QIAGEN Investigator 24plex QS Kit (Cat. No. / ID: 382415). Amplified DNA was analyzed by capillary electrophoresis. For analysis, samples are diluted to a maximum input of 500 pg and applied to the CE (ABI PRISM Genetic Analyzer 3500 XL). Petition 870250103223, dated 11 / 11 / 2025, pages 163 / 182 / 71

[00200] The results are shown in Figures 3a, 3b and 4.

[00201] Figure 3a shows the amount of autosomal DNA isolated from the non-sperm fraction (NSF) after the first non-sperm cell lysis of Sample 1 and Sample 3 (as well as Sample 2 and Sample 4). The starting material was calculated to have a sperm cell quantity equivalent to 0.0007% (0.0006%, respectively) of sperm-associated DNA relative to the DNA originating from the female vaginal swabs. The DNA calculation was based on the amount of DNA and cells that were detached from the swabs during lysis. Figure 3a) shows that the amount of non-sperm (female) DNA in both workflows (i.e., using only one non-sperm cell lysis step or two non-sperm cell lysis steps before lysing the sperm cells and nuclei) is very similar.Consequently, all variations in sperm DNA quantities are expected to result from the chosen workflow and not from variations in the original sample material.

[00202] Figure 3b shows the amount of contaminating autosomal DNA compared to the target male DNA isolated from the sperm fraction of a mixed sample containing epithelial and sperm cells after a single lysis (Sample 1 and Sample 2) compared to a 1a and a 2a subsequent lysis of the non-sperm fraction (Sample 3 and Sample 4).

[00203] Figure 3b) clearly shows that after the first lysis step of the non-sperm cell, a considerable amount of non-sperm cells remains intact and contaminates the sperm cells and nuclei, which are also still intact even after a subsequent DNase digestion step. Thus, when sperm cells and nuclei are lysed in the presence of contaminating non-sperm cells, a considerable amount of female DNA is contaminating the male DNA and makes the analysis of a perpetrator's DNA more difficult (see the tremendously higher amount of autosomal female DNA in Sample 1 and Petition 870250103223, dated 11 / 11 / 2025, pp. 164 / 182 / 71 Sample 2 compared with the relatively low amount of male DNA.

[00204] By conducting two subsequent lyses of the non-sperm fraction with removal of the supernatant lysate from the first lysis before conducting the second lysis, the absolute amount of contaminating autosomal DNA relative to male DNA is tremendously lower. This facilitates the analysis of male DNA, for example, to identify a perpetrator, since the ratio of male DNA compared to contaminating female autosomal DNA is markedly higher (see results for Sample 3 and Sample 4).

[00205] Fig. 4 shows STR DNA profiles of a non-sperm fraction (NSF) and a sperm fraction (SF) subjected to 1a and 2a analysis of the non-sperm fraction.

[00206] Samples were subjected to capillary electrophoresis (CE) on an ABI PRISM Genetic Analyzer 3500 XL and the yellow channel STR alleles were used for identification (see Table 2). DNA isolated from NSF and SF was amplified and STR profiles were generated. For the creation of STR profiles, 500 pg of DNA was used for the “non-sperm fraction” sample and 80 pg as the maximum DNA input in 15 pL for the “sperm fraction, 1a+ 2alises”, calculated according to Figure 3b. Table 2: STR-Allele (yellow channel extract) of male and female donor profiles Female donor Male donor D10S1248 13 14 13 16 D22S1045 16 11 15 D19S433 12 13 14 D8S1179 13 12 13 D2S1338 24 25 17

[00207] The “non-sperm fraction” sample shows alleles that are all concordant with the female donor. The genetic profile of the female donor is the main component, and the additional alleles from the male donor occur only below 200 RFU. Petition 870250103223, dated 11 / 11 / 2025, pages 165 / 182 / 71

[00208] The sample “sperm fraction, 1a+ 2alise” shows alleles that are all concordant with the male donor; the female donor alleles do not occur above the 50 RFU threshold.

[00209] These results show that conducting at least two lysis procedures on non-sperm cells before lysing sperm cells and nuclei makes it significantly easier to obtain a specific genetic profile of a perpetrator without being hindered by the underlying genetic profile of the victim in sexual abuse analyses. Example 3

[00210] In this example, different lysis agents were used following the same procedure as in Example 1. It was shown that the use of various detergents in the lysis buffer can also lead to varying amounts of remaining intact cells after only one lysis, making a second lysis necessary.

[00211] Figure 5 (A&B) shows the amount of remaining DNA isolated from female cell samples after the sample was subjected to a first lysis followed by digestion with DNase (“after DNase digestion”) and after a second lysis (“2-lysis”), where different lysis buffers were used. Parts A and B show the same data, but the DNA yield is plotted on a logarithmic scale (A) or a linear scale with a broken Y-axis (B). Here again the linear scale better illustrates the tremendous differences with respect to the amount of remaining autosomal DNA after DNase and 2-lysis between the various lysis agents used (between 85.926 ng and 0.004 ng), which is more realistically shown in the absolute numbers of the linear scale than on the logarithmic scale.

[00212] Vaginal swabs containing epithelial cells (but no sperm cells) were subjected to a first and second lysis, wherein the lysis solution comprised the different lysis agent listed in Table 3. Petition 870250103223, dated 11 / 11 / 2025, pages 166 / 182 / 71 Table 3: Different lysis agents Agent % by Vol.* Briij58 1% Sodium octyl sulfate (SOS) 0.4% Ecosurf SA9 1% DoTAB 1% Zwittergent 3-08 1% Tween20 1% *% by volume based on the total volume of the lysis solution. Workflow with 1a+ 2 sample analyses

[00213] Vaginal swabs containing epithelial cells (but no sperm cells) were subjected to a first lysis step where the vaginal swab samples were mixed with 500 gL of a first lysis solution comprising 25 gL of Proteinase K and an agent as listed in Table 1. The samples were incubated at 56°C for one hour at 900 rpm and then at 80°C for 10 min.

[00214] The samples were then transferred to a rotating basket (e.g., the QIAshredder-spin basket - QIAGEN) and centrifuged at maximum speed (15,000 rpm) for about 5 minutes, whereby a pellet comprising intact (non-lysed) cells is obtained.

[00215] After removing the supernatant (470 gl of 500 gl), the mixture containing the cell pellet of intact / unlysed cells and the first remaining lysate that could not be removed without disturbing the pellet (about 30 gl) was subjected to digestion with DNase I at 40°C for about 15 min to remove (digest) any DNA present in the mixture.

[00216] A 50 gL aliquot of the mixture after DNase digestion was removed and the DNA present in the “after DNase digestion” fraction was purified using the workflow of the EZ1&2 DNA Investigator Kit (QIAGEN).

[00217] The results “after digestion with DNase” shown in Figure 5 indicate that digestion with DNase was indeed successful, as only slightly above the limit of autosomal DNA was found. Petition 870250103223, dated 11 / 11 / 2025, page 167 / 182 / 71 detection could be detected.

[00218] In the larger quantity of the remaining mixture from the DNase digestion after the aliquot was removed, the DNase enzyme was inactivated by subjecting the sample to heat treatment at 80°C for approximately 10 min.

[00219] After the enzyme was inactivated, the sample (mixture comprising intact (non-lysed) cells and fluid from digestion and DNase inactivation) was subjected to a second lysis.

[00220] For the second lysis, the said sample comprising the intact (non-lysed) cells was mixed with a lysis buffer containing 25 pL of Proteinase K (QIAGEN) and the same agent listed in Table 1 that was used in the first lysis. The sample was incubated at 56°C for approximately one hour. The DNA present in the “2-lysis” fraction was purified using the EZ1&2 DNA Investigator (QIAGEN) workflow.

[00221] The DNA detected in the “2alise” samples was not accessible to DNase and is consequently expected to originate from cells that were not lysed in the first lysis step.

[00222] The amount of DNA that would be detected after the second lysis is supposed to represent the efficiency of the lysis agent in lysing non-sperm cells. It is expected that a lysis agent having reduced efficiency in lysing non-sperm cells will result in a higher quantity of non-sperm cells contained in the mixture resulting from the first lysis. Thus, a higher quantity of DNA should also be obtained after the second lysis. Consequently, the lower the amount of DNA detected in the second lysate, the more efficient the lysis agent used must be in lysing non-sperm cells.

[00223] Quantification was performed using the Investigator Quantiplex Pro Kit (QIAGEN). For the digested samples, the DNA yield was calculated for 50 pl. Example 4 Petition 870250103223, dated 11 / 11 / 2025, pages 168 / 182 / 71

[00224] The ejaculate containing sperm cells was subjected to a lysis step where the sperm samples were mixed with 495 μL of a Tris-based lysis buffer comprising 0.4% SDS, 20 mM EGTA and 25 μL Proteinase K (QIAGEN) and incubated at 56°C for one hour at 900 rpm. The sample was then centrifuged at maximum speed (15,000 rpm) for approximately 5 minutes, obtaining a pellet comprising intact (non-lysed) sperm cells. Most of the lysed supernatant was removed by pipetting. The resulting cell pellet was then washed three times.

[00225] For the first washing step, 500 μL of 10 mM Tris buffer were added to the cell pellet of intact / non-lysed cells and the remaining traces of the first lysate that could not be removed by pipetting without disturbing the pellet (approximately 30 μL). The samples were then centrifuged at maximum speed (15,000 rpm) for approximately 5 minutes, resulting in a pellet comprising intact (non-lysed) cells. Most of the lysed supernatant was removed by pipetting.

[00226] For the second washing step, 500 pL of 10 mM Tris buffer were added to the cell pellet of intact / non-lysed cells and any remaining traces of the first lysate that could not be removed by the first washing step. The sample was then centrifuged at maximum speed (15,000 rpm) for approximately 5 minutes, obtaining a pellet comprising the intact (non-lysed) cells. Most of the lysed supernatant was removed by pipetting.

[00227] For the third washing step, 500 pL of 10 mM Tris buffer were added to the cell pellet of intact / non-lysed cells and any remaining traces of the first lysate that could not be removed by the first and second washing steps. The sample was then centrifuged at maximum speed (15,000 rpm) for approximately 5 Petition 870250103223, dated 11 / 11 / 2025, pp. 169 / 182 / 71 minutes, by which a pellet comprising intact (non-lysed) cells was obtained. Most of the lysed supernatant was removed by pipetting. It was expected that after said third washing step, none or only negligible amounts of non-sperm DNA from the lysate would still be present.

[00228] 100 pL of Tris buffer to 10 mL and 3 pg of purified gDNA from a female donor were added to the cell pellet of intact / non-lysed cells and any remaining traces of the washing buffers and, if any, of the first lysate that could not be removed by the three washing steps. The sample was then divided into three aliquots and subjected to a digestion step or not subjected to a digestion step as specified below.

[00229] The samples in Fig. 6, namely “RecBCD digestion,” were subjected to RecBCD digestion at 37°C for approximately 60 min to remove (digest) any DNA present and contaminating the cell pellet (predominantly enriched female gDNA).

[00230] The samples in Fig. 6, namely “DNasel digestion,” were subjected to digestion with DNasel at 21°C for approximately 15 min to remove (digest) any DNA present in and contaminating the cell pellet (predominantly enriched female gDNA).

[00231] The samples in Fig. 6, namely “no digestion”, were kept at room temperature for 60 min and consequently were not subjected to digestion.

[00232] Next, 440 pL of QIAGEN MTL buffer (Cat. No. / ID: 19112) were added to all samples and carefully mixed to inactivate the digestive enzymes. All samples underwent sperm lysis by applying 36 pL of DTT and incubating at 56°C for approximately one hour at 900 rpm. All samples were purified using the workflow of the EZ1&2 DNA Kit. Petition 870250103223, dated 11 / 11 / 2025, pages 170 / 182 / 71 Investigator (QIAGEN).

[00233] Following purification, the DNA samples were quantified by qPCR in a PCR thermocycler (QIAGEN RotorGene Q Real-Time Systems using the “Investigator Quantiplex Pro RGQ Kit” (QIAGEN Cat. No. / ID: 387316). A maximum of 15 gL of eluate was used for PCR in the QIAGEN Investigator 24plex QS Kit (Cat. No. / ID: 382415). The amplified DNA was analyzed by capillary electrophoresis. For analysis, the samples are diluted to a maximum input of 500 pg and applied to the CE (ABI PRISM Genetic Analyzer 3500 XL).

[00234] The results are shown in Figures 6 and 7.

[00235] The yield of autosomal DNA and male DNA recovered from the sperm cell fraction of a mixed gDNA and sperm cell-containing sample without digestion and after digestion with RecBCD or after digestion with DNaseI is shown in Figure 6a. The DNA degradation ratio of autosomal DNA and male DNA recovered from the sperm cell fraction of a mixed gDNA and sperm cell-containing sample without digestion and after digestion with RecBCD or after digestion with DNaseI is shown in Figure 6b.

[00236] With reference to Figure 6, the three columns show information about the quantity (Fig. 6a) and integrity (Fig. 6b) of DNA isolated from an ejaculate sample after the sample underwent non-sperm cell lysis and additional steps. The lysis solution was adequate to essentially lyse the non-sperm cells and to form a lysate comprising non-sperm DNA, sperm cells and / or sperm nuclei, but the lysis solution did not cause complete lysis of sperm cells and / or sperm nuclei. The additional steps included three washing steps of the remaining cell pellet, the addition of 3 gg of purified gDNA from a female donor, digestion with RecBCD (“RecBCD digestion”) or DNaseI (“DNaseI digestion”) or without Petition 870250103223, dated 11 / 11 / 2025, pp. 171 / 182 / 71 digestion (“no digestion”), as well as digestion inactivation, sperm lysis and subsequent DNA purification.

[00237] Figure 6a shows the “no digestion” sample, a mixed sample comprising male and female DNA used as starting material. The male DNA originated from ejaculate that underwent selective lysis, leading to the lysis of all cells that were not sperm cells. In comparison, a huge amount of autosomal DNA resulted from the addition of 3 pg of female DNA, which were added after the three washing steps. Figure 6a shows that digestion with RecBCD as well as DNasel almost completely eliminated the female gDNA. Digestion with RecBCD did not result in a reduction or loss of the amount of male DNA originating from the isolated sperm cells.Conversely, digestion with DNase I resulted in a tremendous reduction and thus loss of male DNA originating from sperm cells, indicating that DNase I somehow penetrated the sperm nuclei and decomposed the sperm DNA within the sperm nuclei, although it did not induce sperm lysis.

[00238] Figure 6b shows the DNA degradation ratio of autosomal DNA and male DNA, as well as the degradation ratio threshold of 1 (black line). Ratios below 1 and equal to 1 indicate intact DNA, while a ratio greater than 1 indicates DNA degradation. The higher the DNA degradation ratio, the greater the DNA degradation. Fig. 6b shows that the "no digestion" comparison experiment, as expected, showed no degradation of either autosomal or male DNA. A digestion with RecBCD also indicated almost perfect undegraded DNA of approximately 1 for both autosomal and male DNA. However, a digestion with DNase I degraded both autosomal and male DNA.

[00239] Figure 6 shows that digestion with RecBCD almost Petition 870250103223, dated 11 / 11 / 2025, pp. 172 / 182 / 71 completely eliminated female DNA, but did not change the quantity or integrity of sperm DNA. Conversely, digestion with DNase I led to almost complete digestion of female gDNA as well as male DNA and at the same time also to moderate degradation of sperm DNA. Consequently, it appears that DNase I inflicted degradation of sperm DNA within sperm nuclei and sperm cells. Conversely, digestion with RecBCD did not inflict DNA degradation to sperm DNA within sperm nuclei and sperm cells.

[00240] The results of the STR analysis are shown in Figure 7.

[00241] The DNA isolated from the three sample treatments obtained as explained above was amplified and the STR profiles of the DNA obtained from the “no digestion”, “RecBCD digestion” and “DNase I digestion” samples were obtained. A maximum of 15 pL of eluate was used for PCR on the QIAGEN Investigator 24plex QS Kit (Cat. No. / ID: 382415). The amplified DNA was analyzed by capillary electrophoresis (CE) on an ABI PRISM Genetic Analyzer 3500 XL and the yellow channel STR alleles were used for identification as outlined in Table 4. Table 4: STR-Allele (yellow channel extract) of the male donor profile and female gDNA profile_______________________ Female gDNA Male donor D10S1248 12 16 13 16 D22S1045 11 17 11 15 D19S433 12.2 14.2 14 D8S1179 14 15 12 13 D2S1338 20 25 17

[00242] An extract of the STR profiles of the isolated DNA is shown in Figure 7.

[00243] The “no digestion” plot only showed all alleles from the female reference DNA profile in the yellow channel. No alleles from the male reference profile were detected.

[00244] The “RecBCD digestion” graph shows all alleles of the male reference profile as the major component, as well as Petition 870250103223, dated 11 / 11 / 2025, pp. 173 / 182 / 71 additional allenes, lower than the female reference profile as a minor component.

[00245] The “DNase I digestion” graph showed all alleles from the male reference profile as the major component, as well as additional, lower alleles from the female reference profile as a minor component.

[00246] This example demonstrates that both enzymes, RecBCD and DNase I, caused extensive deletion of female DNA, but only the RecBCD enzyme did not inflict degradation on sperm DNA and consequently did not change the integrity of the sperm DNA. Petition 870250103223, dated 11 / 11 / 2025, pp. 174 / 182

Claims

1 / 11 CLAIMS 1. A method for treating a biological sample comprising sperm cells and / or sperm nuclei and non-sperm cells, characterized in that the method comprises: a) subjecting the biological sample comprising sperm cells and / or sperm nuclei and non-sperm cells to a first lysis, applying one or more lysis agents or a lysis solution to the biological sample and / or incubating the biological sample with one or more lysis agents or in the lysis solution, wherein the one or more lysis agents or the lysis solution are suitable for essentially lysing the non-sperm cells and for forming a first lysate comprising non-sperm DNA, sperm cells and / or sperm nuclei, wherein the one or more lysis agents or the lysis solution do not comprise any agent in an amount that causes complete lysis of sperm cells and / or sperm nuclei and, preferably,comprises at least one agent selected from a surfactant, a chaotropic agent, a non-sperm cell digestion enzyme, or any combination thereof; b) optionally, separating and / or removing the unlysed cells and / or sperm nuclei from the first lysate comprising non-sperm DNA and / or decomposing, or separating, or removing, or separating and removing the non-sperm DNA from the first lysate comprising non-sperm DNA, sperm cells and / or sperm nuclei, preferably by subjecting the non-sperm DNA in the first lysate to digestion with nuclease; c) subjecting the unlysed cells and / or sperm nuclei to at least a second lysis, applying one or more lysis agents or a lysis solution to the unlysed cells and / or sperm nuclei and / or incubating the unlysed cells and / or sperm nuclei with one or more lysis agents or in the lysis solution, wherein the one or more lysis agents or Petition 870250103223, dated 11 / 11 / 2025,Page 84 / 182 2 / 11 The lysis solution is suitable for essentially lysing non-sperm cells and for forming a second or additional lysate comprising non-sperm DNA, wherein one or more lysis agents or the lysis solution do not comprise any agent in an amount that causes complete lysis of sperm cells and / or sperm nuclei and preferably comprise at least one agent selected from a surfactant, a chaotropic agent, a non-sperm cell digestion enzyme, or any combination thereof; d) decompose, or separate, or remove, or separate and remove the non-sperm DNA from the second or additional lysate comprising non-sperm DNA, preferably by subjecting the non-sperm DNA in the second or additional lysate to digestion with nuclease; ee) subject the non-lysed cells to at least a third or additional lysis,applying a sperm cell and / or sperm nucleus lysis solution or one or more lysis agents to completely lyse sperm cells and / or sperm nuclei and to form a third or additional lysate comprising sperm DNA, wherein the sperm cell and / or sperm nucleus lysis solution or the one or more lysis agents comprise at least one sperm cell and / or sperm nucleus lysis agent selected from a reducing agent, a sperm cell and / or sperm nucleus lysis enzyme, a chaotropic agent at a concentration suitable for lysing sperm cells and / or sperm nuclei, and / or an alkaline agent at a concentration suitable for lysing sperm cells and / or sperm nuclei, or a combination thereof.

2. Method according to claim 1, characterized in that the biological sample is a forensic sample, such as a forensic swab sample, preferably a sexual abuse sample.

3. Method according to claim 1 or 2, characterized in Petition 870250103223, dated 11 / 11 / 2025, page 85 / 182 3 / 11 by the fact that method step c) has at least one of the following features: i) the non-lysed cells are incubated in the lysate, in one or more lysis agents or in the lysis solution of step a); ii) a lysis solution is applied to the non-lysed cells, and the lysis solution comprises the same agents in the same concentration and / or amounts as the lysis solution in method step a); iii) the lysis agents are not applied to the non-lysed cells in the form of a pre-prepared solution, but directly; iv) the non-lysed cells are resuspended before or during the application of the lysis solution or of one or more lysis agents; (v) the lysis solution or one or more lysis agents are applied to the lysate obtained in step (a) without further separation and / or removal of the unlysed cells from step (b);vi) the lysis solution or one or more lysis agents are applied to the unlysed cells after their separation and / or removal from the lysate in step b); vii) the lysis solution or one or more lysis agents are different from the lysis solution or one or more lysis agents in method step a) in at least one agent and / or at least one concentration or amount of agent; viii) the lysis solution or one or more lysis agents are applied to the lysate obtained in step a) after the non-sperm DNA present in the first lysate has been decomposed, or separated, or removed, or separated and removed from the first lysate in step b).

4. Method according to any one of claims 1 to 3, characterized in that the separation, removal, or separation and removal of non-lysed cells and / or sperm nuclei occurs through centrifugation, preferably by forming a pellet of non-lysed cells and / or sperm nuclei, through filtration, through binding to a solid matrix, preferably a membrane or microspheres, preferably magnetic microspheres.

5. Method according to any one of claims 1 to 4, characterized in that it further comprises, after method step b) and / or d), at least one washing step of the non-lysed cells and / or sperm nuclei and / or cell pellet.

6. A method according to any one of claims 1 to 5, characterized in that the lysis solution or one or more lysis agents in steps a) and / or c) comprise at least one agent selected from a surfactant selected from the group consisting of nonionic surfactants or ionic surfactants, such as anionic, cationic or zwitterionic surfactants; a chaotropic agent selected from the group consisting of one or more sodium salts, thiocyanate salts or guanidinium salts or urea; a non-sperm cell digestion enzyme selected from the group consisting of proteinase K, protease, zymolase, lyticase, chromopeptidase, lysostaphin, lysozyme, nuclease, such as DNase, Benzonase(R), RNase, endonucleases and exonucleases; or any combination thereof.

7. Method according to claim 6, characterized in that one or more surfactants have one or more of the following features: i) the surfactant is selected from an anionic surfactant; ii) the surfactant is selected from a nonionic surfactant; iii) the surfactant is selected from an anionic and / or a nonionic surfactant; iv) the surfactant is selected from a cationic surfactant; v) the surfactant is selected from a zwitterionic surfactant; Petition 870250103223, dated 11 / 11 / 2025, page 87 / 182 5 / 11 vi. the surfactant is selected from two or more of the surfactants indicated in i. av; vii) the anionic surfactant is selected from the group consisting of sodium dodecyl sulfate (SDS), sarcosyl deoxycholate, sodium lauryl ether sulfate (SLS), sodium octyl sulfate (SOS), sodium methyl cocoyl taurate and disodium coco sulfosuccinates, or a combination thereof;viii) The nonionic surfactant is selected from the group consisting of Triton X-100, Triton X-114, N-octylglucoside, Tween 20 (polysorbate 20, polyoxyethylene (20) sorbitan monolaurate), Tween 40, Tween 80, Span 80, Span 85, Ecosurf EH-6, Brij-35 (polyalkylene glycol ether), NP-40 (nonylphenoxypolyethoxyethanol), Nonidet P-40 (octylphenoxypolyethoxyethanol), Ecosurf EH-9, Ecosurf SA-9, Tergitol 15-S-7, Tergitol 15-S-9, Tergitol 15-S-15, Tergitol 15-S-30, Tergitol 15-S-40, Tergitol 15-S-5, Brij35, Brij C10 (=Brij 56), Brij58, BrijS20 (=Brij78), Brij98, Poloxamer 188 (=Synperonic F68), Genapol X-080, Genapol X-100, Genapol X-150, Genapol C-100, Genapol C-200, Genapol X-050, Genapol X060, Pluronic F-127, MEGA-8, MEGA-9, MEGA-12, MEGA-10, APO-10, APO-12, Big CHAP, Big CHAP Deoxy, Pluronic P-123, Pluronic L64 and Pluronic 17R4, or a combination thereof.

8. A method according to any one of claims 1 to 6, characterized in that the chaotropic agent is selected from the group consisting of sodium iodide, sodium perchlorate, guanidinium hydrochloride, guanidinium thiocyanate, guanidinium isothiocyanate, urea and / or a mixture of two or more salts thereof.

9. Method according to any one of claims 1 to 8, characterized in that the lysis solution or one or more lysis agents applied in method step c) are free of nuclease inhibitors, preferably free of chelating agents such as ethylenediaminetetraacetic acid (EDTA) and / or free of anionic detergents such as sodium dodecyl sulfate (SDS), sarcosyl deoxycholate, sodium lauryl ether sulfate (SLS), sodium octyl sulfate (SOS), sodium methyl cocoyl taurate and disodium coco sulfosuccinates or mixtures thereof.

10. Method according to any one of claims 1 to 9, characterized in that the nuclease digestion in step b) and / or d) is carried out by one or more nucleases comprising Turbonuclease, all members of the DNAse I family, all members of the DNAse II family, Micrococcus nuclease, Nuclease P1, Nuclease S1, Phosphodiesterase I, Phosphodiesterase II, Restriction Endonucleases, Salt-Activated Nuclease (SAN), RNase I, Turbo Nuclease (=Benzonase®), BAL 31 Nuclease, Cryonase Cold-Activated Nuclease, Mung Bean Nuclease, Thermolabile Exonuclease I, Exonuclease Mst I, Exonuclease T, RecJf, T7 Exonuclease, RecBCD (Exonuclease V), truncated Exonuclease VIII, Lambda Exonuclease, T5 Exonuclease, DNase I-XT, DNaseMe, Saltonase, Masterase, Azotobacter nuclease, SM nuclease, Neurospora nuclease, Bacillus nucleases, Strptomycex Nucleases, C1 Nuclease, Yeast Nuclease, Leishmania Nuclease, Staphylococcal Nuclease, Bal 31 nuclease, Anabaena Nuclease,Lysobacter Nuclease, Vibrio Nuclease, Schizosaccharomyces Nuclease, Rsn Nuclease, SR Nuclease, Rye Germ Nuclease-I, Rye Germ Nuclease-II, Peunia Pollen Nuclease, Barley Nuclease, Wheat Nuclease, Potato Nuclease, Tobacco Pollen Nuclease, Barley Microspore Nuclease, Nuclease A, Drosophila Nuclease, Drosophila Embryo Nuclease, Shrimp Nuclease, Rat Liver Nuclease, Endonuclease G, Calf Thymus Nuclease, Phospholipase D Family, Caspase-activated DNase (CAD), DNase gamma (DNase γ), Msz Exonuclease I, Exonuclease I, Exonuclease II, Exonuclease III, Exonuclease IV Exonuclease VI, Exonuclease VII, Exonuclease VIII, Exonuclease IX, Exonuclease X, Cyclophilin, NUC-18 and Lactoferrin.

11. Method according to claim 10, characterized in Petition 870250103223, dated 11 / 11 / 2025, page 89 / 182 7 / 11 by the fact that the nuclease has at least one of the following features: i) it has a size of 50 kDa or above; ii) it has a size of 60 kDa, 80 kDa, 100 kDa, 150 kDa, 200 kDa, 250 kDa, 300 kDa, 350 kDa or preferably 400 kDa or above, or any size between these; iii) it is selected from the group comprising EcoR1 restriction endonuclease, Phosphodiesterase I, Phosphodiesterase II, Exonuclease I, Exonuclease V (RecBCD), Exonuclease VII and Lactoferrin; iv) it has multiple independent functions; v) it has helicase activity; vi) it has endonuclease activity; vii) it has exonuclease activity; viii) it has both helicase and endonuclease activity; ix) it has both helicase and exonuclease activity; x) it has both endonuclease and exonuclease activity;xi) it has helicase activity, endonuclease activity, and exonuclease activity; xii) the nuclease is selected so that it does not have access to packaged DNA; xiii) the nuclease is chosen so that it digests and / or decomposes non-sperm DNA, but not sperm DNA; xiv) the nuclease can recognize and be altered by the Chi DNA sequence.

12. Method according to any one of claims 1 to 11, characterized in that the sperm lysis agent or lysis agents contain a reducing agent selected from the group consisting of dithiothreitol (DTT), dithioerythrityl, β-mercaptoethanol (BME), glutathione (GSH), Tris(2-carboxyethyl)phosphine (TCEP) and combinations thereof; a sperm lysis enzyme selected from the group consisting of proteinase K, protease, zymolase, lyticase, chromopeptidase, trypsin, lysostaphin, lysozyme and / or combinations thereof; a chaotropic agent and / or an alkaline agent in a concentration suitable for lysing sperm cells and / or sperm nuclei; or a combination thereof.

13. Method according to claim 1, characterized in that it further comprises purifying, isolating, detecting, analyzing and / or quantifying non-sperm DNA and / or sperm DNA.

14. A method according to claim 13, characterized in that the analysis comprises genotyping DNA, preferably a short tandem repeat (STR) analysis, restriction fragment length polymorphism (RFLP) of genomic DNA, randomized amplified polymorphic detection (RAPD) of genomic DNA, amplified fragment length polymorphism (AFLP) detection, single nucleotide polymorphism (SNP) detection, polymerase chain reaction (PCR), DNA sequencing, allele-specific oligonucleotide (ASO) probes, and hybridization to DNA microarrays or microspheres; or any combination thereof.

15. Method according to claim 1, characterized in that one or more steps are automated.

16. Kit, characterized in that it comprises one or more of: a) a first non-sperm cell lysis solution or one or more non-sperm cell lysis agents capable of lysing non-sperm cells and essentially unsuitable for completely lysing sperm cells and / or sperm nuclei;b) a second non-sperm cell lysis solution and / or Petition 870250103223, dated 11 / 11 / 2025, page 91 / 182 9 / 11 an additional or one or more non-sperm cell lysis agents capable of lysing non-sperm cells and not suitable for completely lysing sperm cells and / or sperm nuclei, wherein the second non-sperm cell lysis solution and / or an additional or one or more non-sperm cell lysis agents are identical to the first non-sperm cell lysis solution or to the one or more non-sperm cell lysis agents used in a), or wherein the second non-sperm cell lysis solution and / or an additional or one or more non-sperm cell lysis agents are different from the first non-sperm cell lysis solution or from the one or more non-sperm cell lysis agents used in a); c) optionally, one or more washing compositions; d) optionally, one or more DNA digestion enzymes;(e) a sperm cell and / or sperm nucleus lysis solution or one or more sperm cell and / or sperm nucleus lysis agents capable of lysing sperm cells and / or sperm nuclei, preferably the sperm cell and / or sperm nucleus lysis solution or one or more lysis agents comprising at least one reducing agent selected from the group consisting of dithiothreitol (DTT), dithioerythrityl, β-mercaptoethanol (BME), glutathione (GSH), Tris(2-carboxyethyl)phosphine (TCEP) and combinations thereof; a sperm lysis enzyme selected from the group consisting of proteinase K, protease, zymolase, lyticase, chromopeptidase, trypsin, lysostaphin, lysozyme and / or combinations thereof; a chaotropic agent and / or an alkaline agent in a concentration suitable for lysing sperm cells and / or sperm nuclei; or any combination thereof.

17. Method for treating a biological sample comprising sperm cells and / or sperm nuclei and non-sperm cells, characterized in that the method comprises: Petition 870250103223, dated 11 / 11 / 2025, page. 92 / 182 10 / 11 i) subjecting the biological sample comprising sperm cells and / or sperm nuclei and non-sperm cells to lysis, applying one or more lysis agents or a lysis solution to the biological sample and / or incubating the biological sample with one or more lysis agents or in the lysis solution, wherein the one or more lysis agents or the lysis solution are suitable for essentially lysing the non-sperm cells and for forming a first lysate comprising non-sperm DNA, sperm cells and / or sperm nuclei, wherein the one or more lysis agents or the lysis solution do not comprise any agent in an amount that causes complete lysis of sperm cells and / or sperm nuclei and,Preferably, it comprises at least one agent selected from a surfactant, a chaotropic agent, a non-sperm cell digestion enzyme, or any combination thereof; ii) decomposing most or all of the non-sperm DNA obtained from the lysate in step i) using an enzyme having helicase and exonuclease activity and / or having a size above 50 kDa while not, or not markedly, decomposing the sperm DNA; and iii) subjecting the unlysed cells to a second lysis by applying a sperm cell and / or sperm nucleus lysis solution or one or more lysis agents to completely lyse sperm cells and / or sperm nuclei and to form a second or additional lysate comprising sperm DNA.wherein the sperm cell and / or sperm nucleus lysis solution or one or more lysis agents comprise at least one sperm cell and / or sperm nucleus lysis agent selected from a reducing agent, a sperm cell and / or sperm nucleus lysis enzyme, a chaotropic agent at a concentration suitable for lysing a sperm cell and / or sperm nucleus, and / or an alkaline agent at a concentration suitable for lysing sperm cells and / or sperm nuclei, or a combination thereof. Petition 870250103223, dated 11 / 11 / 2025, p. 93 / 182 11 / 11, 18. Use of a nuclease having exonuclease and helicase activity and / or having a size greater than 50 kilodaltons (kDa), characterized by being for the decomposition of non-sperm DNA in a sample comprising a mixture of non-sperm DNA and sperm DNA, the sperm DNA being contained in sperm cells and / or sperm nuclei. Petition 870250103223, dated 11 / 11 / 2025, p. 94 / 182